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Introduction {#mbo3288-sec-0001}
============

*Mycobacterium smegmatis*, a fast‐growing saprophytic environmental bacterium, is used as a surrogate to study mycobacterial physiology and gene regulation as it is easy to culture in laboratory conditions. Owing to its habitat, *M. smegmatis* encounters more diverse conditions than its pathogenic counterparts and consequently its genome (6.98 Mb) has expanded nearly twice to the size of *M*. *tuberculosis* (4.4 Mb) to accommodate more genes. There is an unusual expansion of several genes which have acquired many paralogs unlike in other mycobacterial species (Waagmeester et al. [2005](#mbo3288-bib-0041){ref-type="ref"}). There are 28 sigma factor genes in *M. smegmatis* in contrast with 13 reported in *M. tuberculosis* (Cole et al. [1998](#mbo3288-bib-0005){ref-type="ref"}; Waagmeester et al. [2005](#mbo3288-bib-0041){ref-type="ref"}; Rodrigue et al. [2006](#mbo3288-bib-0031){ref-type="ref"}) and there are seven paralogs of sigma factor *sigH*, which are differentially expressed in *M. smegmatis* (Waagmeester et al. [2005](#mbo3288-bib-0041){ref-type="ref"}; Singh and Singh [2009](#mbo3288-bib-0035){ref-type="ref"}). Sigma factors reversibly associate with RNA polymerase and allow them to specifically direct the expression of specific set of genes. *M. smegmatis* genome encodes one of each group I, II, and III sigma factors represented by SigA, SigB, and SigF, respectively, and 25 of group IV sigma factors (Kapopoulou et al. [2011](#mbo3288-bib-0022){ref-type="ref"}). SigA, the primary sigma factor in both *M. smegmatis* and *M. tuberculosis*, is essential for bacterial viability (Gomez et al. [1998](#mbo3288-bib-0013){ref-type="ref"}), while SigB, the primary‐like sigma factor is very similar to SigA and is dispensable for growth in *M. smegmatis* (Fontán et al. [2009](#mbo3288-bib-0009){ref-type="ref"}). SigF (group III) and extracytoplasmic function (ECF) sigma factors (group IV) constitute alternate sigma factors which enable adaptation to a range of external and internal stimuli. Locus for *sigA*,*sigB*,*sigD*,*sigE*,*sigF*,*sigG,* and *sigH* are well conserved in *M. smegmatis* and *M. tuberculosis* (Sachdeva et al. [2010](#mbo3288-bib-0032){ref-type="ref"}).

Earlier, the *sigF* was reported as a late‐stage specific sigma factor, present only in the genomes of slow‐growing pathogenic mycobacteria (DeMaio et al. [1996](#mbo3288-bib-0006){ref-type="ref"}, [1997](#mbo3288-bib-0007){ref-type="ref"}). *M. tuberculosis sigF* was found strongly induced within cultured human macrophages, during stationary phase of growth, upon exposure to cold shock, nutrient starvation, and several antibiotics (Graham and Clark‐Curtiss [1999](#mbo3288-bib-0015){ref-type="ref"}; Michele et al. [1999](#mbo3288-bib-0026){ref-type="ref"}; Betts et al. [2002](#mbo3288-bib-0002){ref-type="ref"}). *M. tuberculosis* Δ*sigF* strain grew to a threefold higher density in stationary phase than the wild‐type strain (Chen et al. [2000](#mbo3288-bib-0004){ref-type="ref"}), but showed almost similar sensitivity to heat shock, cold shock, and hypoxia relative to the parental strain (Geiman et al. [2004](#mbo3288-bib-0012){ref-type="ref"}; Hartkoorn et al. [2010](#mbo3288-bib-0017){ref-type="ref"}). *M. tuberculosis* Δ*sigF* strain was attenuated for virulence in a mouse infection model despite persistence at high bacterial load in lungs compared with the isogenic wild type (Geiman et al. [2004](#mbo3288-bib-0012){ref-type="ref"}). Overexpression of *sigF* in *M. tuberculosis* resulted in the differential regulation of many cell wall‐associated proteins and other genes involved in the biosynthesis and degradation of surface polysaccharides and lippolysaccharides, believed to play important roles in host‐pathogen interactions (Williams et al. [2007](#mbo3288-bib-0042){ref-type="ref"}; Hartkoorn et al. [2010](#mbo3288-bib-0017){ref-type="ref"}). However, we earlier demonstrated that, *sigF* is conserved in all the mycobacterial species analyzed and proposed that apart from regulating the expression of virulence genes in pathogenic mycobacteria, SigF is likely to play more roles in mycobacterial physiology (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}).

In *M. smegmatis*,*sigF* is widely expressed during different growth stages (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}). *M. smegmatis sigF* is transcriptionally induced in response to nutrient depletion, cold shock and upon exposure to agents that damage cell wall architecture, like SDS and antibiotics, isoniazid, and ethambutol (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}; Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}). A *sigF* mutant of *M. smegmatis* ATCC 607 strain showed higher transformation efficiency, lack of carotenoid pigmentation, and increased susceptibility to hydrogen peroxide mediated oxidative stress (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}). SigF in *M. smegmatis* plays role in adaptation to stationary phase, heat, and oxidative stress (Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}). While both these studies demonstrate the role of *M*. *smegmatis* SigF in oxidative stress, molecular basis of this increased sensitivity to hydrogen peroxide remains unclear. Furthermore, proteins involved in post‐translation regulation of *M. smegmatis* SigF activity are not characterized, making it difficult to define the regulation circuitry of this alternate sigma factor. Using an insertion deletion mutant of *M. smegmatis* mc^2^ 155 *sigF*, we demonstrate that SigF in *M. smegmatis* modulates the cell surface architecture and lipid biosynthesis, extending the repertoire of SigF function in this species. We also demonstrate that the increased sensitivity of the *sigF* mutant to H~2~O~2~ mediated oxidative stress is primarily due to loss of the carotenoid pigment. Furthermore, we report the identification of a SigF antagonist, an anti‐sigma factor (RsbW), which upon overexpression in *M. smegmatis* wild type strain produced a phenotype similar to *M. smegmatis* mc^2^155 Δ*sigF* strain. The SigF‐anti‐SigF interaction was duly confirmed using bacterial two‐hybrid system and pull down assay. In addition, anti‐sigma factor antagonists, RsfA and RsfB were identified and their interactions with anti‐sigma factor were verified using two‐hybrid system.

Results and Discussion {#mbo3288-sec-0002}
======================

Construction of *Mycobacterium smegmatis sigF* knockout mutant and its complementation {#mbo3288-sec-0003}
--------------------------------------------------------------------------------------

The *sigF* deletion (Δ*sigF*) mutant was created by replacing *sigF* ORF with the hygromycin (*hyg*) resistance cassette and molecularly validated (see supplemental material, Fig. S1) as detailed in methods. One of the Δ*sigF* mutants referred as SFKO1 has been studied and described throughout this manuscript. The SFKO1 was complemented with the *sigF* gene, cloned downstream of *hsp60* promoter, at an ectopic locus in the SFKO1 genome. The *sigF* complemented strain is designated as SFKO1/*sigF*.

Role of SigF in stress responses {#mbo3288-sec-0004}
--------------------------------

The effect of *sigF* deletion on in vitro growth was monitored by comparing the growth of the SFKO1 strain to the wild type *M. smegmatis*. Both strains were allowed to grow in different media for extended length of time; the *sigF* mutant strain grew slightly faster than the wild type, attained higher cell density with reduced lag phase, but displayed similar growth characteristics afterwards till extended stationary phase of growth (data not shown). This suggests that the *sigF* is dispensable for the growth of *M. smegmatis* under normal physiological conditions. These results are in line with the earlier findings (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}).

SigF has been described as a stress‐response sigma factor in slow‐growing mycobacteria (DeMaio et al. [1996](#mbo3288-bib-0006){ref-type="ref"}). Previously, we had shown that *sigF* is transcriptionally induced in *M*. *smegmatis* in response to cold shock, nutrient starvation and after treatment with SDS and antimycobacterial drugs like isoniazid and ethambutol (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}). We examined whether SigF is required for survival of *M. smegmatis* during these stress conditions. No significant differences in survival were noticed between the *sigF* mutant and the wild type strain under these stress conditions (data not shown). Gebhard et al. (Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}) had reported that SigF is required for survival against heat shock and acidic stress in *M. smegmatis*. We did not test the acidic stress but upon heat shock no appreciable difference in survival of *sigF* mutant was noticed in comparison to the wild type strain. We checked the *sigF* deletion mutants of both *M. smegmatis* mc^2^155 (SFKO1) and *M. smegmatis* ATCC 607 strains. One of the reasons of this difference could be the temperature as we tested the survival, based on our earlier studies (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}, [2009](#mbo3288-bib-0035){ref-type="ref"}), at 45°C while they used 50°C for heat stress in their studies.

But, similar to earlier findings (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}), the *sigF* deletion mutant was found to be more susceptible than the wild type strain upon exposure to hydrogen peroxide mediated oxidative stress (Fig. [1](#mbo3288-fig-0001){ref-type="fig"}A). Complemented strain (SFKO1/*sigF*) restored the survival after oxidative stress. Since, *sigF* was not found to be induced upon oxidative stress in previous studies (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}), we examined the *sigF* expression at RNA and protein level after treatment with hydrogen peroxide. No difference in the *sigF* expression level was noticed upon oxidative stress using log phase and stationary phase cultures (Fig. [1](#mbo3288-fig-0001){ref-type="fig"}B and C). This suggests that SigF indirectly regulates H~2~O~2~ sensitivity in *M. smegmatis*.

![Oxidative stress susceptibility of Δ*sigF* mutant despite similar level of *sigF* expression at RNA and protein level during oxidative stress. (A) *Mycobacterium smegmatis* WT (MS), MSΔ*sigF* mutant (SFKO1) and MSΔ*sigF/sigF* complemented (SFKO1/*sigF*) strains were subjected to oxidative stress (10 mmol L^−1^ H~2~O~2~) and their percent survival were calculated as described in methods. Susceptibility of Δ*sigF* mutant to oxidative stress is completely restored after complementation with *sigF*. Data were collected from three different experiments. The mean values and standard deviations were plotted for each set of data. \*\**P *\<* *0.01 relative to *M. smegmatis* wild type (MS) as determined by paired *t*‐test. (B) Quantitative real time RT‐PCR analysis of *sigF* gene expression after oxidative stress (10 mmol L^−1^ H~2~O~2~). Relative expression was determined with reference to untreated control (corresponding to 1.0 at *Y* axis). The expression of genes was normalized with the *sigA* transcript level. The mean value and standard deviations were calculated from two different experiments and plotted for each set of data. (C) Western blot of SigF protein using protein samples from exponential and stationary phase cultures under treated (10 mmol L^−1^ H~2~O~2~) and untreated conditions. Apparently similar levels of SigF proteins were detected in treated and untreated samples. Gel picture shows equal loading of proteins.](MBO3-4-0896-g001){#mbo3288-fig-0001}

Loss of carotenoid pigment renders increased H~2~O~2~ sensitivity to the *sigF* mutant {#mbo3288-sec-0005}
--------------------------------------------------------------------------------------

Disparate response to oxidative stress was reported in saprophytic and pathogenic mycobacteria (Sherman et al. [1995](#mbo3288-bib-0033){ref-type="ref"}). Saprophytes like *M. aurum* and *M. smegmatis* produce carotenoids, which are known scavengers of free radicals (Levy‐Frebault and David [1979](#mbo3288-bib-0025){ref-type="ref"}) and enhance the strength of the cell wall due to their lipophilic nature and intercalation into the cell membrane (Kubler and Baumeister [1978](#mbo3288-bib-0024){ref-type="ref"}). *M. smegmatis* mc^2^155 colonies produce pale yellow pigment (carotenoid isorenieratene) when incubated under light for 5--6 days. Deletion of *sigF* resulted in loss of pigmentation in SFKO1 (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A) which was mostly restored after complementation with the *sigF* gene (SFKO1/*sigF*) (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A), suggesting that the loss of pigmentation is specifically due to deletion of *sigF*. Because carotenoids are robust antioxidants and fortifiers of cellular barriers they are deemed beneficial for withstanding the stress beard by saprophyte like *M. smegmatis*. Since, we did not find the appreciable differences in the *sigF* expression after peroxide mediated oxidative stress despite the marked sensitivity of the Δ*sigF* mutant to H~2~O~2~, we reasoned that this phenotypic characteristic of the *M. smegmatis* Δ*sigF* mutant might be due to absence of carotenoids in the mutant. Moreover, the key detoxifying enzymes of reactive oxygen species in mycobacteria, *katG* and *ahpC* were found to be SigF independent (Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}; Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}). To test our hypothesis, we treated *M. smegmatis* mc^2^155 cells with diphenylamine (DPA), a known inhibitor of carotenogenesis in mycobacteria (Houssaini‐Iraqui et al. [1993](#mbo3288-bib-0020){ref-type="ref"}), and subjected the DPA‐treated bacterial cells to hydrogen peroxide mediated oxidative stress. The DPA‐treated bacteria showed pronounced sensitivity to oxidative stress, comparable to *M. smegmatis* Δ*sigF* mutant strain (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}B). This was duly confirmed when SFKO1/*crt* strain apart from restoring the pigmentation (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A) showed a significant recovery in survival following hydrogen peroxide mediated oxidative stress akin to SFKO1/*sigF* strain (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}B).

![Complementation of Δ*sigF* mutant with *crt* locus genes restores the wild type phenotype. (A) Loss of pigmentation in Δ*sigF* mutant (SFKO1) is restored in *sigF* (SFKO1/*sigF*) and *crt* (SFKO1/*crt*) complemented strains, similar to *Mycobacterium smegmatis* WT (MS). (B) Treatment with DPA (0.1 mmol L^−1^) reduces survival of *M. smegmati*s WT (MS) cells to 80% with respect to untreated control (100%). DPA treated MS cells when exposed to H~2~O~2~ showed reduced survival which was relatively similar to H~2~O~2~ treated Δ*sigF* mutant cells and much lower than wild type treated cells. Susceptibility of Δ*sigF* mutant to oxidative stress is completely restored after complementation with *sigF* and nearly to a similar extent after complementation with *crt* locus genes. Data were collected from three different experiments. The mean values and standard deviations were plotted for each set of data. \**P* \< 0.05, \*\**P* \< 0.01 relative to H~2~O~2~ treated *M. smegmati*s WT (H~2~O~2~/MS) as determined by paired *t*‐test. (C) Expression of *crtI* gene in SFKO1. In complemented strain SFKO1/*sigF* expression was restored to almost wild type level. The expression of genes was normalized with the *sigA* transcript level. The mean value and standard deviations were calculated from two different experiments and plotted for each set of data.](MBO3-4-0896-g002){#mbo3288-fig-0002}

Carotene isorenieratene is the characteristic pigment of almost all orange‐pigmented mycobacteria including *M. phlei* (Goodwin and Jamikorn [1956](#mbo3288-bib-0014){ref-type="ref"}, [1956](#mbo3288-bib-0014){ref-type="ref"}), *M. aurum* (Levy‐Frebault and David [1979](#mbo3288-bib-0025){ref-type="ref"}), *M. avium,* and *M. intracellulare* (Tarnok and Tarnok [1970](#mbo3288-bib-0039){ref-type="ref"}, [1970](#mbo3288-bib-0039){ref-type="ref"}). The synthesis of isorenieratene requires farnesyl pyrophosphate as a precursor, which leads to isorenieratene in five metabolic steps involving, CrtE, CrtB, CrtI, CrtY, and CrtU (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}). It was postulated that in the absence of SigF, transcription of *crt* operon is off, hence SFKO1 mutant lacks pigmentation. Evidently, *crtI* transcript was found to be several‐fold downregulated in SFKO1 mutant in comparison to wild type strain (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}C) and the expression (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}C) as well as pigmentation (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A) were restored, almost to the wild type level, in the complemented SFKO1/*sigF* strain. In *M. smegmatis* genome, a carotenogenic gene cluster comprises six open reading frames, *crtIBYcYdUV*, each transcribed in the same direction. The GGPP synthase gene, *crtE*, was found far away from the *crt* locus. The upstream regions of *crtI* gene harbored a canonical SigF promoter signature (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}). When *crt* locus genes were overexpressed in SFKO1/*crt* strain, SFKO1/*crt* akin to SFKO1/*sigF*, restored the pigmentation (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A) which was lost due to *sigF* deletion, suggesting that the SigF directly regulates the carotenoid biosynthesis and thereby the pigmentation of bacterial colonies in *M. smegmatis*. These results established that in *M. smegmatis* SigF confers resistance to hydrogen peroxide mediated oxidative stress largely through the carotenoid pigments.

SigF modulates cell wall architecture by affecting GPL distribution and lipid biosynthesis {#mbo3288-sec-0006}
------------------------------------------------------------------------------------------

Previously, in *M. smegmatis*, we observed increased *sigF* expression upon exposure to isoniazid, ethambutol, and SDS (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}). Isoniazid and ethambutol specifically target cell wall biosynthesis process in mycobacteria, whereas SDS is an ionic detergent that affects the cell wall architecture. Overexpression of *sigF* in *M. tuberculosis* was reported to alter the regulation of many cell wall‐associated proteins, suggesting a role for SigF in maintaining cell wall architecture in mycobacteria (Forrellad et al. [2013](#mbo3288-bib-0010){ref-type="ref"}). To examine the effect of *sigF* deletion on the cell wall architecture in *M. smegmatis*, we performed transmission electron microscopy using *M. smegmatis* WT and Δ*sigF* mutant cells. In *M*. *smegmatis*, GPLs constitute the major cell‐surface glycolipids and react with ruthenium red to give the electron‐dense appearance to the outermost cell envelope layer (Etienne et al. [2002](#mbo3288-bib-0008){ref-type="ref"}). We noticed uniform distribution of GPLs on the surface of WT cells (Fig. [3](#mbo3288-fig-0003){ref-type="fig"}A), while Δ*sigF* mutant cells displayed patchy GPLs distribution (Fig [3](#mbo3288-fig-0003){ref-type="fig"}B). Next, we analyzed the total GPLs in wild type and Δ*sigF* mutant by TLC and mass analysis (see supplemental material, Fig. S2), but no difference was found in GPLs profile of Δ*sigF* mutant, suggesting that the uneven distribution of GPLs in the Δ*sigF* mutant cells is not due to difference in overall content and type of GPLs. Then, we examined the profiles of other cell wall lipids. TLC analysis of polar lipids also did not reveal any differences (data not shown), but nonpolar lipids showed distinct TLC profiles. Lipids spots present in wild type cells (Fig. [4](#mbo3288-fig-0004){ref-type="fig"}A and C) were conspicuously missing in Δ*sigF* mutant cells (Fig. [4](#mbo3288-fig-0004){ref-type="fig"}B and D). We also noticed distinct differences in trehalose containing lipids (Fig. [4](#mbo3288-fig-0004){ref-type="fig"}E and F), an important component for cell wall integrity, indicating that the SigF alters the cell wall lipid composition by modulating the lipid biosynthesis pathway.

![Transmission electron micrographs showing structure of cell envelope of *M. smegmatis* wild type (A) and Δ*sigF* mutant (B) strains. Note the even distribution of GPLs around wild type cells while distribution of GPLs is patchy in mutant cells.](MBO3-4-0896-g003){#mbo3288-fig-0003}

![2D TLC analysis of nonpolar lipids from *Mycobacterium smegmatis* wild type (A, C, E) and Δ*sigF* mutant (B, D, F). Different solvent systems, described in methods, were used to develop TLC plates: A and B developed with solvent system B, C, and D developed with solvent system C, E, and F developed with solvent system D. The arrows indicate the missing fatty acids (FA) in Δ*sigF* mutant (B and D) and TMM (Trehalose monomycolate), TDM (Trehalose dimycolate) in panel F.](MBO3-4-0896-g004){#mbo3288-fig-0004}

Genome‐wide gene expression studies of *Mycobacterium smegmatis ΔsigF* mutant and wild‐type strains {#mbo3288-sec-0007}
---------------------------------------------------------------------------------------------------

A genome‐wide gene expression analysis of the *M. smegmatis* mc^2^155 WT and Δ*sigF* mutant strains was performed using Agilent microarray platform. SigF‐regulated genes during exponential phase and stationary phase were indentified, as described in the methods. Difference in the expression of a gene was calculated as the Δ*sigF* mutant to WT expression ratio and is expressed as fold‐change; only ≥ 2‐fold difference in the gene expression (*P* ≤ 0.05) was considered for analysis. Under these conditions, 142 genes in exponential phase and 158 genes in stationary phase were found to be significantly down‐regulated in the Δ*sigF* mutant. A large number of genes showed reduced expression in both exponential and stationary phase cells, and almost similar numbers of genes were found to be down‐regulated exclusively in exponential and stationary phase cells (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}). We also identified enhanced expression of 39 genes in exponential phase cells and 49 genes in stationary phase cells in Δ*sigF* mutant strain. The entire expression data can be found in Data set S1 in the supplemental material. To validate the microarray results, real‐time PCR was performed on few randomly selected genes from microarray data. Similar to microarray results, the selected genes showed reduced expressions in real‐time PCR experiment (see supplemental material, Fig. S3) as well.

###### 

Genes with reduced expressions in Δ*sigF* strain

  Locus                                                                                Description                                        Fold‐change Exponential/Stationary   SigF consensus     Position from start codon
  ------------------------------------------------------------------------------------ -------------------------------------------------- ------------------------------------ ------------------ ---------------------------
  **Commonly down‐regulated genes (*P* ≤ 0.05) in exponential and stationary phase**                                                                                                              
  MSMEG_0266[a](#mbo3288-note-0003){ref-type="fn"}                                     Arginine decarboxylase                             −4.44/−5.90                          GTCG‐N~17~‐GGGAT   160
  MSMEG_0267[a](#mbo3288-note-0003){ref-type="fn"}                                     Esterase                                           −5.49/−4.58                          GTTT‐N~15~‐GGGTA   27
  **MSMEG_0278**                                                                       Hypothetical protein                               −2.22/−2.90                          GGTT‐N~14~‐GGGCC   
  **MSMEG_0280**                                                                       Alpha/beta hydrolase                               −1.93/−4.30                          GGTT‐N~14~‐GGGCC   158
  MSMEG_0375                                                                           Phospholipase D family protein                     −3.98/−2.91                          GTTC‐N~19~‐GGGCA   192
  MSMEG_0451[a](#mbo3288-note-0003){ref-type="fn"}                                     Oxidoreductase, FAD‐linked                         −4.69/−3.40                          GTTC‐N~19~‐GGGCC   49
  MSMEG_0521                                                                           Conserved hypothetical protein                     −2.42/−1.76                          GTTT‐N~16~‐GGGTA   10
  MSMEG_0637                                                                           Iron‐sulfur binding oxidoreductase                 −6.02/−3.33                          GTCG‐N~14~‐GGGCA   548
  MSMEG_0669                                                                           Hypothetical protein                               −5.44/−2.52                          GTTC‐N~14~‐GGGCC   661
  MSMEG_0670[a](#mbo3288-note-0003){ref-type="fn"}                                     FAD dependent oxidoreductase                       −2.06/−3.17                          GGTT‐N~16~‐GGGTA   9
  MSMEG_0671[a](#mbo3288-note-0003){ref-type="fn"}                                     S‐(hydroxymethyl) glutathione dehydrogenase        −3.75/−4.97                          GTTT‐N~15~‐GGGTA   47
  MSMEG_0672[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −1.73/−3.73                          GTTT‐N~15~‐GGGTA   50
  **MSMEG_0684**                                                                       Aldehyde oxidase and xanthine dehydrogenase        −5.15/−5.17                          GTTG‐N~15~‐GGGTA   
  **MSMEG_0685**                                                                       Oxidoreductase, molybdopterin‐binding subunit      −5.09/−5.49                          GTTG‐N~15~‐GGGTA   
  **MSMEG_0686** [a](#mbo3288-note-0003){ref-type="fn"}                                Oxidoreductase                                     −3.87/−3.26                          GTTG‐N~15~‐GGGTA   8
  **MSMEG_0696**                                                                       Alanine‐rich protein                               −4.86/−5.90                          GTTT‐N~16~‐GGGAA   
  **MSMEG_0697** [a](#mbo3288-note-0003){ref-type="fn"}                                Integral membrane protein                          −4.37/−4.66                          GTTT‐N~16~‐GGGAA   58
  MSMEG_1076[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −5.82/−2.58                          GTTT‐N~16~‐GGGTA   50
  MSMEG_1097[a](#mbo3288-note-0003){ref-type="fn"}                                     Glycosyl transferase, group 2 family protein       −5.63/−5.01                          GTGT‐N~15~‐GGGTT   11
  MSMEG_1112[a](#mbo3288-note-0003){ref-type="fn"}                                     Aconitate hydratase, putative                      −5.96/−5.32                          CGTT‐N~16~‐GGGAA   8
  MSMEG_1131[a](#mbo3288-note-0003){ref-type="fn"}                                     Tryptophan‐rich sensory protein                    −5.33/−4.80                          GTGT‐N~16~‐GGGTA   9
  MSMEG_1315[a](#mbo3288-note-0003){ref-type="fn"}                                     Transporter                                        −4.17/−2.56                          GTTG‐N~17~‐GGGTA   11
  MSMEG_1361                                                                           Alpha‐mannosidase                                  −2.20/−2.13                          GTCG‐N~19~‐GGGTG   541
  MSMEG_1605                                                                           PhoU                                               −2.50/−3.21                          GTCC‐N~15~‐GGGTT   22
  MSMEG_1758[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −4.54/−2.95                          GTTT‐N~16~‐GGGTA   8
  **MSMEG_1766** [a](#mbo3288-note-0003){ref-type="fn"}                                Conserved hypothetical protein                     −6.28/−6.24                          GTTT‐N~16~‐GGGAA   32
  **MSMEG_1767**                                                                       Conserved hypothetical protein                     −5.70/−6.47                          GTTT‐N~16~‐GGGAA   
  **MSMEG_1768**                                                                       Conserved hypothetical protein                     −5.50/−6.05                          GTTT‐N~16~‐GGGAA   
  **MSMEG_1769**                                                                       UsfY protein                                       −5.91/−4.14                          GTTT‐N~16~‐GGGAA   
  MSMEG_1770[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −5.89/−3.34                          GTTT‐N~16~‐GGGCA   64
  MSMEG_1771[a](#mbo3288-note-0003){ref-type="fn"}                                     Methylase, putative                                −6.17/−5.69                          GTTT‐N~15~‐GGGTA   29
  MSMEG_1772                                                                           Conserved hypothetical protein                     −5.91/−6.43                          GTTT‐N~15~‐GGGTA   696
  MSMEG_1773[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −5.98/−4.09                          GTTT‐N~15~‐GGGAA   11
  MSMEG_1774[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −6.17/−4.13                          GTTT‐N~16~‐GGGTA   64
  MSMEG_1775[a](#mbo3288-note-0003){ref-type="fn"}                                     Cytochrome P450 monooxygenase                      −3.84/−3.01                          GTTT‐N~15~‐GGGTA   9
  MSMEG_1777[a](#mbo3288-note-0003){ref-type="fn"}                                     UsfY protein‐                                      −4.98/−6.43                          GTTT‐N~16~‐GGGTA   69
  **MSMEG_1778**                                                                       Conserved hypothetical protein                     −3.16/−5.02                          GTTT‐N~15~‐GGGTA   
  **MSMEG_1779**                                                                       Hypothetical protein                               −3.64/−4.24                          GTTT‐N~15~‐GGGTA   
  **MSMEG_1780**                                                                       Hypothetical protein                               −3.06/−4.79                          GTTT‐N~15~‐GGGTA   
  **MSMEG_1781**                                                                       Hypothetical protein                               −6.29/−5.71                          GTTT‐N~15~‐GGGTA   
  **MSMEG_1782** [a](#mbo3288-note-0003){ref-type="fn"}                                Oxidoreductase, dehydrogenase/reductase            −5.87/−6.15                          GTTT‐N~15~‐GGGTA   221
  **MSMEG_1783**                                                                       Hypothetical protein                               −3.48/−3.45                          GTGT‐N~16~‐GGGTA   
  **MSMEG_1784** [a](#mbo3288-note-0003){ref-type="fn"}                                Type I topoisomerase                               −4.30/−3.46                          GTGT‐N~16~‐GGGTA   183
  MSMEG_1787[a](#mbo3288-note-0003){ref-type="fn"}                                     RsbW protein                                       −3.10/−5.90                          GTTT‐N~17~‐GGGTA   56
  **MSMEG_1788**                                                                       Conserved hypothetical protein                     −3.80/−3.37                          GGTT‐N~15~‐GGGCA   32
  **MSMEG_1789**                                                                       Conserved hypothetical protein                     −6.02/−6.41                          GGTT‐N~15~‐GGGCA   
  **MSMEG_1790**                                                                       Conserved hypothetical protein                     −5.79/−6.31                          GGTT‐N~15~‐GGGCA   
  MSMEG_1792[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein ‐                   −3.47/−4.44                          GGGT‐N~14~‐GGGCA   268
  MSMEG_1794[a](#mbo3288-note-0003){ref-type="fn"}                                     Dehydrogenase                                      −5.60/−5.72                          GTGT‐N~17~‐GGGTA   15
  MSMEG_1801[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −1.69/−4.23                          GGTG‐N~18~‐GGGAA   173
  MSMEG_1802[a](#mbo3288-note-0003){ref-type="fn"}                                     ChaB protein                                       −4.71/−4.70                          GTTT‐N~16~‐GGGCA   63
  MSMEG_1804                                                                           RNA polymerase sigma‐F factor                      −5.96/−5.79                          GTTT‐N~16~‐GGGCA   1001
  MSMEG_1853[a](#mbo3288-note-0003){ref-type="fn"}                                     Na+/H+ antiporter NhaA                             −2.14/−2.15                          GTTT‐N~15~‐GGGTA   99
  **MSMEG_1950**                                                                       Conserved hypothetical protein                     −5.96/−4.67                          GTCG‐N~16~‐GGGCA   354
  **MSMEG_1951**                                                                       Conserved domain protein                           −5.70/−5.50                          GTCG‐N~16~‐GGGCA   
  **MSMEG_2112** [a](#mbo3288-note-0003){ref-type="fn"}                                Secreted protein                                   −2.09/−1.58                          GTTT‐N~15~‐GGGTA   24
  **MSMEG_2115**                                                                       Conserved hypothetical protein                     −4.09/−5.02                          GTTT‐N~15~‐GGGTA   
  **MSMEG_2343**                                                                       Methylesterase (part of *crt* locus, 2343--2347)   −5.70/−5.37                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2344**                                                                       Dehydrogenase                                      −5.01/−5.09                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2345**                                                                       Lycopene cyclase                                   −5.62/−6.23                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2346**                                                                       Phytoene synthase                                  −5.80/−6.21                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2347** [a](#mbo3288-note-0003){ref-type="fn"}                                Phytoene dehydrogenase                             −5.66/−4.48                          GTTT‐N~16~‐GGGTA   97
  MSMEG_2376                                                                           Conserved hypothetical protein                     −4.29/−5.23                          GTTC‐N~19~‐GGGCC   49
  MSMEG_2415[a](#mbo3288-note-0003){ref-type="fn"}                                     Hemerythrin HHE cation binding region              −1.45/−4.80                          GTTG‐N~15~‐GGGTA   61
  MSMEG_2594                                                                           Asparagine synthase (glutamine‐hydrolyzing)        −2.17/−3.76                          CTTC‐N~15~‐GGGTG   321
  MSMEG_2837[a](#mbo3288-note-0003){ref-type="fn"}                                     Nitrate reductase NarB                             −4.43/−3.16                          GTTT‐N~16~‐GGGTA   42
  MSMEG_2838                                                                           Conserved hypothetical protein                     −3.91/−3.09                          GTTT‐N~16~‐GGGTA   
  MSMEG_2913[a](#mbo3288-note-0003){ref-type="fn"}                                     Hydrolase                                          −5.87/−4.88                          GTTT‐N~15~‐GGGTA   3
  **MSMEG_2924**                                                                       Permease binding‐protein component                 −5.78/−3.65                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2925**                                                                       Permease membrane component                        −5.77/−5.79                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2926**                                                                       Glycine betaine/carnitine/choline transport        −5.77/−4.41                          GTTT‐N~16~‐GGGTA   
  **MSMEG_2927** [a](#mbo3288-note-0003){ref-type="fn"}                                ABC transporter, permease protein OpuCB            −4.94/−4.06                          GTTT‐N~16~‐GGGTA   39
  MSMEG_2958[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −3.79/−5.19                          GTTC‐N~15~‐GGGTA   24
  MSMEG_3022[a](#mbo3288-note-0003){ref-type="fn"}                                     Transglycosylase associated protein                −5.76/−4.06                          GTTT‐N~16~‐GGGTA   30
  MSMEG_3083                                                                           Nucleoside‐diphosphate sugar epimerase             −1.75/−4.88                          GCTT‐N~16~‐GGGTA   451
  MSMEG_3141[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved domain protein                           −3.03/−1.90                          GTGT‐N~16~‐GGGTA   29
  MSMEG_3255[a](#mbo3288-note-0003){ref-type="fn"}                                     DoxX subfamily, putative                           −3.16/−5.18                          GTTT‐N~15~‐GGGAA   36
  MSMEG_3289[a](#mbo3288-note-0003){ref-type="fn"}                                     gp61 protein                                       −5.33/−5.60                          GTTT‐N~15~‐GGGTA   29
  MSMEG_3304[a](#mbo3288-note-0003){ref-type="fn"}                                     Succinate semialdehyde dehydrogenase               −4.71/−5.73                          GTGT‐N~15~‐GGGTA   25
  MSMEG_3310                                                                           Integral membrane protein                          −3.40/−2.13                          GTGT‐N~18~‐GGGCA   248
  MSMEG_3311                                                                           Acyl carrier protein                               −2.54/−2.83                          GTCG‐N~17~‐GGGAA   255
  MSMEG_3418                                                                           Conserved hypothetical protein                     −3.73/−2.54                          GTCG‐N~14~‐GGGTA   1115
  MSMEG_3419                                                                           Hypothetical protein                               −5.54/−4.43                          GTCG‐N~14~‐GGGTA   58
  MSMEG_3439[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −5.55/−4.00                          GTTT‐N~15~‐CGGTA   59
  MSMEG_3443[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −1.31/−3.85                          GTTT‐N~15~‐GGGAT   45
  MSMEG_3536[a](#mbo3288-note-0003){ref-type="fn"}                                     Sugar transport protein                            −3.75/−2.48                          GTGG‐N~16~‐GGGTA   134
  MSMEG_3673[a](#mbo3288-note-0003){ref-type="fn"}                                     4‐alpha‐glucanotransferase                         −1.35/−4.92                          GTTT‐N~16~‐GGGCA   195
  MSMEG_4707[a](#mbo3288-note-0003){ref-type="fn"}                                     Nonhaem bromoperoxidase                            −2.68/−1.51                          GTTT‐N~15~‐GGGTA   35
  MSMEG_4918[a](#mbo3288-note-0003){ref-type="fn"}                                     1,4‐alpha‐glucan branching enzyme                  −2.21/−2.54                          GGTT‐N~15~‐GGGTA   172
  **MSMEG_5188**                                                                       Caax amino protease family                         −3.92/−3.01                          GGTT‐N~16~‐GGGTA   
  **MSMEG_5189** [a](#mbo3288-note-0003){ref-type="fn"}                                Oxidoreductase                                     −3.42/−3.69                          GGTT‐N~16~‐GGGTA   25
  MSMEG_5342                                                                           Conserved hypothetical protein                     −5.55/−5.21                          GTTT‐N~16~‐GGCTA   386
  MSMEG_5399                                                                           ATP‐dependent DNA helicase RecQ                    −3.01/−3.11                          GTTT‐N~15~‐GGGTA   
  MSMEG_5400                                                                           Dehydrogenase                                      −4.36/−2.19                          GTTT‐N~15~‐GGGTA   
  MSMEG_5401                                                                           Conserved hypothetical protein                     −3.58/−5.87                          GTTT‐N~15~‐GGGTA   
  MSMEG_5402[a](#mbo3288-note-0003){ref-type="fn"}                                     Dehydrogenase DhgA                                 −5.99/−4.80                          GTTT‐N~15~‐GGGTA   8
  MSMEG_5496                                                                           MscS Mechanosensitive ion channel                  −3.78/−3.41                          GTCT‐N~16~‐GGGGA   80
  MSMEG_5540                                                                           Conserved hypothetical protein                     −2.59/−2.34                          GTTT‐N~17~‐GGGTA   792
  MSMEG_5542                                                                           Transcriptional regulator, HTH_3 family            −4.82/−4.69                          GTTT‐N~17~‐GGGTA   518
  MSMEG_5543[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −5.13/−5.91                          GTTT‐N~17~‐GGGTA   77
  MSMEG_5590                                                                           Carboxylate‐amine ligase                           −5.48/−3.09                          GTTT‐N~15~‐GGGCA   14
  MSMEG_5605                                                                           Cytochrome bd ubiquinol oxidase, subunit I         −2.07/−3.47                          GGTG‐N~19~‐GGGAA   73
  MSMEG_5616                                                                           Glyoxalase/bleomycin resistance protein            −4.87/−1.79                          GTTT‐N~15~‐GGGTA   647
  MSMEG_5617[a](#mbo3288-note-0003){ref-type="fn"}                                     Immunogenic protein MPT63                          −3.63/−5.99                          GTTT‐N~15~‐GGGTA   70
  MSMEG_5799                                                                           Nucleoside‐diphosphate‐sugar epimerase             −4.69/−3.76                          GTTC‐N~16~‐GGGAT   849
  MSMEG_5826                                                                           Pyruvate decarboxylase                             −3.78/−3.79                          GTTG‐N~14~‐GGGCA   711
  MSMEG_6211[a](#mbo3288-note-0003){ref-type="fn"}                                     Hypothetical protein                               −4.39/−4.12                          GGTT‐N~15~‐GGGTA   9
  MSMEG_6212[a](#mbo3288-note-0003){ref-type="fn"}                                     Hemerythrin HHE cation binding domain              −5.43/−3.87                          GTTT‐N~15~‐GGGTA   51
  MSMEG_6213[a](#mbo3288-note-0003){ref-type="fn"}                                     Manganese containing catalase                      −4.18/−5.96                          GTTT‐N~15~‐GGGTA   40
  MSMEG_6232[a](#mbo3288-note-0003){ref-type="fn"}                                     Catalase KatA                                      −5.95/−5.17                          GTTT‐N~16~‐GGGAA   67
  MSMEG_6305[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −5.04/−2.49                          GTTT‐N~16~‐GGGCA   8
  MSMEG_6354                                                                           Serine esterase, cutinase family                   −4.67/−5.88                          GGTG‐N~16~‐GGGAA   1058
  MSMEG_6355                                                                           Hypothetical protein                               −5.39/−4.85                          GTTC‐N~16~‐GGGAC   19
  MSMEG_6467[a](#mbo3288-note-0003){ref-type="fn"}                                     Starvation‐induced DNA protecting protein          −5.72/−5.55                          GTTC‐N~16~‐GGGCA   100
  MSMEG_6501                                                                           Hypothetical protein                               −3.17/−2.95                          GTCG‐N~17~‐GGGCC   1008
  **MSMEG_6514**                                                                       Trehalose synthase‐fused maltokinase               −1.98/−2.75                          GTGT‐N~16~‐GGGTA   
  **MSMEG_6515**                                                                       Trehalose synthase                                 −2.03/−2.58                          GTGT‐N~16~‐GGGTA   10
  **MSMEG_6606**                                                                       Hypothetical protein                               −3.15/−2.45                          GTTC‐N~14~‐GGGCA   
  **MSMEG_6607**                                                                       Hypothetical protein                               −3.51/−2.52                          GTTC‐N~14~‐GGGCA   
  **MSMEG_6608**                                                                       Hypothetical protein                               −4.87/−2.97                          GTTC‐N~14~‐GGGCA   
  **MSMEG_6609**                                                                       Hypothetical protein                               −5.21/−4.43                          GTTC‐N~14~‐GGGCA   
  **MSMEG_6610**                                                                       Protein of unknown function DUF58                  −5.50/−2.49                          GTTC‐N~14~‐GGGCA   
  **MSMEG_6612**                                                                       ATPase, MoxR family                                −6.20/−4.25                          GTTC‐N~14~‐GGGCA   147
  **MSMEG_6615**                                                                       Hypothetical protein                               −5.45/−6.20                          GTTT‐N~15~‐GGGTA   
  **MSMEG_6616**                                                                       S‐(hydroxymethyl)glutathione dehydrogenase         −4.93/−4.93                          GTTT‐N~15~‐GGGTA   32
  MSMEG_6664                                                                           Methylenetetrahydrofolate reductase family         −5.52/−3.67                          GTTT‐N~15~‐GGGAA   462
  **MSMEG_6665** [**a**](#mbo3288-note-0003){ref-type="fn"}                            Integral membrane protein                          −1.42/−4.25                          GTTT‐N~15~‐GGGAA   8
  **MSMEG_6667**                                                                       Conserved hypothetical protein                     −4.80/−3.43                          GTTT‐N~15~‐GGGAA   
  MSMEG_6727                                                                           Amino acid permease‐associated region              −6.51/−6.32                          GCTT‐N~15~‐GGGTA   56
  MSMEG_6728                                                                           Conserved hypothetical protein                     −5.57/−4.75                          GTGG‐N~15~‐GGGTG   165
  MSMEG_6730                                                                           Putative oxidoreductase YdbC                       −2.93/−2.09                          GTTG‐N~18~‐GGGTA   462
  **MSMEG_6765**                                                                       ABC‐2 type transporter superfamily                 −2.52/−3.69                          GGTG‐N~18~‐GGGTA   
  **MSMEG_6766**                                                                       ABC transporter, ATP‐binding protein               −3.91/−3.99                          GGTG‐N~18~‐GGGTA   
  **MSMEG_6767**                                                                       Mycocerosic acid synthase                          −3.39/−2.59                          GGTG‐N~18~‐GGGTA   58
  MSMEG_6768[a](#mbo3288-note-0003){ref-type="fn"}                                     Halogenase                                         −4.57/−5.79                          GCTT‐N~16~‐GGGTA   9
  MSMEG_6769                                                                           Transporter                                        −4.11/−2.93                          GGTG‐N~16~‐GGGAT   649
  MSMEG_6812                                                                           Major facilitator superfamily                      −1.86/−2.46                          GGTT‐N~14~‐GGGGA   22
  **Genes exclusively down‐regulated in exponential phase (*P* ≤ 0.05)**                                                                                                                          
  MSMEG_0482                                                                           Dihydroxy‐acid dehydratase                         −2.67/1.40                                              
  MSMEG_0586                                                                           STAS domain, putative                              −2.76/0.43                                              
  MSMEG_0651                                                                           Putative conserved exported protein                −2.21/0.74                           GTTC‐N~19~‐GGGTG   1171
  MSMEG_0757                                                                           Hypothetical protein                               −2.22/0.79                                              
  MSMEG_1114                                                                           Short chain dehydrogenase                          −2.07/1.31                           GTCG‐N~19~‐GGGGA   155
  MSMEG_1656                                                                           Exodeoxyribonuclease III                           −2.34/−0.06                          GTCG‐N~17~‐GGGCC   20
  MSMEG_1912                                                                           Muconolactone delta‐isomerase 1                    −3.08/−0.96                          GCTT‐N~18~‐GGGCA   348
  MSMEG_2024                                                                           Hydroxymethylglutaryl‐CoA lyase                    −2.90/−0.07                          GTCG‐N~17~‐GGGCC   66
  MSMEG_2425[a](#mbo3288-note-0003){ref-type="fn"}                                     Ammonium transporter                               −2.17/0.13                           GTTC‐N~17~‐GGGTA   238
  MSMEG_3137                                                                           Oxidoreductase                                     −2.33/1.77                           GTGG‐N~14~‐GGGGA   992
  MSMEG_3401                                                                           LamB/YcsF family protein                           −2.68/−0.38                                             
  MSMEG_3402                                                                           Cytosine permease, putative                        −2.39/0.65                                              
  MSMEG_3403                                                                           Formamidase                                        −3.48/0.58                           GGTT‐N~14~‐GGGTT   1004
  MSMEG_3417                                                                           Conserved hypothetical protein                     −4.63/−1.19                          GTGG‐N~15~‐GGGTG   402
  MSMEG_3541                                                                           Cytochrome C biogenesis protein                    −4.19/0.11                           GTTT‐N~14~‐GGGGA   676
  MSMEG_3562                                                                           4‐carboxymuconolactone decarboxylase               −2.41/0.96                                              
  MSMEG_3583                                                                           Monooxygenase                                      −2.72/0.51                           GGTG‐N~14~‐GGGCC   470
  MSMEG_3660                                                                           Conserved hypothetical protein                     −2.33/0.91                                              
  MSMEG_3927                                                                           Peptidase M52, hydrogen uptake protein             −3.34/1.03                                              
  MSMEG_3928                                                                           \[NiFe\] hydrogenase, alpha subunit, putative      −2.49/1.28                           GTCG‐N~14~‐GGGTG   345
  MSMEG_3929                                                                           \[NiFe\] hydrogenase, delta subunit, putative      −2.51/0.76                           GTTG‐N~16~‐GGGCC   150
  MSMEG_3945                                                                           Universal stress protein family                    −2.60/0.40                           GGTG‐N~16~‐GGGCC   571
  MSMEG_3983                                                                           L‐carnitine dehydratase                            −2.35/1.16                                              
  MSMEG_4329                                                                           Propionyl‐CoA carboxylase beta chain               −2.36/−0.49                          GGTG‐N~16~‐GGGCC   1037
  MSMEG_4424                                                                           Endoribonuclease L‐PSP                             −3.48/1.03                                              
  MSMEG_4618                                                                           Isochorismatase family protein                     −3.08/0.79                                              
  MSMEG_5100                                                                           Pyruvate ferredoxin/flavodoxin oxidoreductase      −3.82/0.72                           GGTG‐N~15~‐GGGGA   361
  MSMEG_5180                                                                           Conserved hypothetical protein                     −2.41/−0.84                          GTTG‐N~14~‐GGGTG   233
  MSMEG_5341                                                                           Dipeptidyl aminopeptidase                          −2.22/0.91                                              
  MSMEG_5343[a](#mbo3288-note-0003){ref-type="fn"}                                     Conserved hypothetical protein                     −3.09/−1.07                          GTTT‐N~16~‐GGCTA   35
  MSMEG_5374                                                                           Glutamate‐ammonia ligase                           −2.22/−0.03                                             
  MSMEG_5559                                                                           Metabolite/sugar transport protein                 −2.83/0.35                           GTTT‐N~16~‐GGGTA   39
  MSMEG_5623                                                                           L‐carnitine dehydratase                            −3.24/1.20                           GTTC‐N~15~‐GGGCA   51
  MSMEG_5731                                                                           Transcriptional regulator, GntR family             −2.31/0.25                           GTCT‐N~18~‐GGGAT   785
  MSMEG_6507                                                                           Glycogen debranching enzyme GlgX                   −2.27/0.93                           GGTG‐N~14~‐GGGAT   656
  MSMEG_6508                                                                           MarR‐family transcriptional regulator              −2.82/3.11                           GCTT‐N~17~‐GGGCC   142
  MSMEG_6528                                                                           Conserved hypothetical protein                     −3.82/0.91                                              
  MSMEG_6611                                                                           Hypothetical protein                               −2.83/2.43                                              
  MSMEG_6820                                                                           Acid phosphatase SurE                              −3.26/−0.98                          GTTG‐N~13~‐GGGTA   87
  **Genes exclusively down‐regulated in stationary phase (*P* ≤ 0.05)**                                                                                                                           
  MSMEG_0195                                                                           Steroid monooxygenase                              0.30/−2.66                           GTTG‐N~16~‐GGGAT   403
  MSMEG_0964                                                                           Pyridoxamine 5‐phosphate oxidase family            −0.42/−5.10                          GTTT‐N~16~‐GGGCA   259
  MSMEG_1196                                                                           SNF2 domain protein                                0.05/−2.47                                              
  MSMEG_1297                                                                           Hydroxydechloroatrazine thylaminohydrolase         −0.08/−2.82                                             
  MSMEG_1658                                                                           Ribonuclease, putative                             −0.54/−3.26                          GTCT‐N~17~‐GGGTA   50
  MSMEG_1803                                                                           RsbW protein                                       −1.23/−3.56                          GTTT‐N~16~‐GGGCA   548
  MSMEG_1807[a](#mbo3288-note-0003){ref-type="fn"}                                     Acetyl‐/propionyl‐coenzyme A carboxylase           0.07/−2.38                           GGTT‐N~17~‐GGGTA   294
  MSMEG_2373                                                                           Acetolactate synthase, small subunit               0.15/−2.83                           GTTG‐N~17~‐GGGCA   386
  MSMEG_3082[a](#mbo3288-note-0003){ref-type="fn"}                                     Heme‐binding protein                               −0.47/−3.59                          GCTT‐N~16~‐GGGTA   67
  MSMEG_3157                                                                           Conserved hypothetical protein                     0.70/−2.22                                              
  MSMEG_3184                                                                           Malto‐oligosyltrehalose trehalohydrolase           −1.30/−3.83                          GTGT‐N~15~‐GGGCA   409
  MSMEG_3254                                                                           RDD family, putative                               −0.96/−3.85                          GTTT‐N~15~‐GGGAA   923
  MSMEG_3273                                                                           Glutamyl aminopeptidase, M42 family                −0.57/−3.38                          GCTT‐N~15~‐GGGCC   164
  MSMEG_3322                                                                           Hypothetical protein                               −0.46/−2.14                                             
  MSMEG_3358                                                                           YaeQ protein                                       −0.61/−2.01                                             
  MSMEG_3593                                                                           Protein of unknown function                        −0.70/−4.74                          GTTT‐N~14~‐GGGCA   987
  MSMEG_4082                                                                           Monoxygenase                                       0.38/−2.17                           GTTG‐N~14~‐GGGCC   1024
  MSMEG_4355                                                                           Peptide ABC transporter, permease protein          −1.20/−3.44                          GGTT‐N~15~‐GGGCC   13
  **MSMEG_4356**                                                                       Inner membrane ABC transporter permease            −0.82/−3.24                          GTTC‐N~14~‐GGGCC   139
  **MSMEG_4357**                                                                       ABC transporter, ATP‐binding protein               −0.80/−3.48                          GTTC‐N~14~‐GGGCC   
  **MSMEG_4358**                                                                       D‐beta‐hydroxybutyrate dehydrogenase               −0.44/−2.91                          GTTC‐N~14~‐GGGCC   
  MSMEG_4428                                                                           Conserved hypothetical protein                     1.01/−3.26                                              
  **MSMEG_4531**                                                                       Sulfate ABC transporter, permease CysW             0.98/−3.99                           GTCG‐N~15~‐GGGTT   
  **MSMEG_4532**                                                                       Sulfate ABC transporter, permease CysT             1.10/−2.41                           GTCG‐N~15~‐GGGTT   
  **MSMEG_4533**                                                                       Sulfate‐binding protein                            1.36/−2.58                           GTCG‐N~15~‐GGGTT   756
  MSMEG_4864                                                                           3‐ketosteroid dehydrogenase                        −0.03/−2.49                          GTTC‐N~18~‐GGGGA   81
  MSMEG_4991                                                                           Hypothetical protein                               −1.66/−6.01                          GGTG‐N~17~‐GGGCC   47
  MSMEG_4993                                                                           Hypothetical protein                               −1.52/−4.00                          GTGT‐N~19~‐GGGCA   408
  MSMEG_5003                                                                           O‐methyltransferase, family                        −0.05/−3.82                                             
  MSMEG_5301                                                                           Transcriptional regulator                          −0.19/−2.10                                             
  MSMEG_5491                                                                           Putative acyl‐CoA dehydrogenase                    0.51/−2.00                           GTGT‐N~17~‐GGGTT   783
  MSMEG_5606                                                                           Cytochrome bd‐I oxidase subunit II                 −1.24/−3.75                          GTTG‐N~14~‐GGGTT   625
  MSMEG_5880                                                                           Nicotine dehydrogenase                             0.78/−2.05                           GCTT‐N~17~‐GGGAA   733
  MSMEG_5936                                                                           Conserved hypothetical protein                     −1.18/−3.80                                             
  MSMEG_6151                                                                           Alpha/beta hydrolase fold‐1                        −0.12/−2.26                                             
  MSMEG_6210                                                                           Conserved hypothetical protein                     −1.04/−3.38                                             
  MSMEG_6541[a](#mbo3288-note-0003){ref-type="fn"}                                     Anti‐sigma factor antagonist                       −0.66/−3.63                          GTTT‐N~15~‐GGGTA   282
  MSMEG_6819                                                                           Conserved domain protein                           −1.70/−4.01                                             
  MSMEG_6822[a](#mbo3288-note-0003){ref-type="fn"}                                     Beta‐lactamase                                     −0.28/−2.61                          GTTT‐N~16~‐GGGTA   46

Fold‐change in expression -- Δ*sigF* strain/wild‐type gene expression ratio in log2 scale. SigF consensus (GTTT‐N~(14--19)~ -- GGGTA) was found in the upstream regions of majority of the down‐regulated genes. Locus IDs in bold refer to genes that are clustered as operon in the genome. SigF consensus in such cases was found either in ORFs of preceding genes or in far upstream of the first gene of the cluster, e.g. SigF consensus was present 97 bp upstream of MSMEG_2347, MSMEG_2343--MSMEG_2347 constitute *crt* locus. ^a^Genes found down‐regulated in Hümpel et al. ([2010](#mbo3288-bib-0021){ref-type="ref"}) as well as in this study.
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The SigF promoter consensus in *M. smegmatis* was first identified *in silico* (Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}), and was later improved upon by experimental data (Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}; Provvedi et al. [2008](#mbo3288-bib-0029){ref-type="ref"}; Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}). Using an improved SigF promoter consensus from later studies, 1200 bp upstream of the annotated start codon of the down‐regulated genes (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}) were visually checked for sequence similarities. We searched 1200 bp upstream sequence because several genes were arranged in gene clusters wherein the SigF consensus was found far upstream of the down‐regulated genes or even in the ORFs of the preceding genes. It may be noted that the canonical SigF promoter consensus was located more than 1000 bp upstream of the *sigF* gene in *M. smegmatis* genome (Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}). We reasoned that the SigF‐dependent genes are likely to be down‐regulated in both stages of growth. Notably, genes that showed reduced expressions commonly in exponential as well as stationary phase cells, most of them showed the presence of the SigF promoter consensus in their upstream regions (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}), suggesting that they are SigF‐dependent. Majority of genes that showed reduced expressions in this study were also reported to be down‐regulated by Humpel et al. (Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}). They identified the SigF promoter consensus in the upstream regions of transcriptional regulators, *sigH3* (MSMEG_0573), *whiB1* (MSMEG_1919), *whiB4* (MSMEG_6199), and *phoP* (MSMEG_5872), but the expressions of these genes were found unaltered in the Δ*sigF* mutant. In this study, using our selection criteria (≥2‐fold, *P* ≤ 0.05), we identified three transcriptional regulators; MSMEG_5542 (HTH3 family), MSMEG_5731 (GntR family), and MSMEG_6508 (MarR family) which showed reduced expression in exponential phase, and MSMEG_5542, MSMEG_5301 (TetR family) with reduced expression in stationary phase. Of these MSMEG_5542, 5731, 6508 were found to have SigF consensus in their upstream regions. It is likely that the down‐regulated genes which did not show SigF foot‐prints in their upstream regions are indirectly regulated by SigF‐dependent transcriptional regulators. Several of the exclusively down‐regulated genes from exponential and stationary phase cells also showed SigF promoter consensus in their upstream regions, while few of them were found lacking the consensus. Based on the SigF promoter sequences, identified from this study, we deduced a profile of the SigF promoter consensus (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}), which showed the similar occurrence of the nucleotides at a given position in the earlier reported SigF promoter signature (Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}).

*Mycobacterium smegmatis* Δ*sigF* mutant phenotype and SigF regulon {#mbo3288-sec-0008}
-------------------------------------------------------------------

The *M. smegmatis* Δ*sigF* mutant displayed notable phenotypes likes, loss of pigmentation, pronounced sensitivity to oxidative stress and alteration in the cell wall architecture due to patchy distribution of GPLs in the cell wall. Correlating the loss of pigmentation phenotype the expressions of carotenoid biosynthesis genes (MSMEG_2243--MSMEG_2247) were found to be down‐regulated during both growth stages (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}). The SigF promoter consensus was identified in the upstream of the cluster and the reduced expression of *crtI*, the first gene of the cluster, was validated by real time PCR (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}C). Complementation of the Δ*sigF* mutant restored the original phenotype (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}A).

Regarding the sensitivity to oxidative stress the expressions of key enzymes that detoxify reactive oxygen intermediates, *katG* and *ahpC*, were found unaltered in the mutant strain, suggesting these genes are not regulated by SigF. We demonstrated that the overexpression of *crt* locus genes largely restores the susceptibility of Δ*sigF* strain to oxidative stress. Moreover, several genes which could possibly render resistance to Δ*sigF* strain against oxidative stress were found to be SigF‐dependent and showed reduced expressions in both growth stages of Δ*sigF* strain. Two potential hydrogen peroxide detoxifying enzymes, exclusively present in *M. smegmatis*, a manganese containing catalase (MSMEG_6213) and a heme containing catalase KatA (MSMEG_6232), showed reduced expressions in both stages in present study as well as in earlier report (Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}). A starvation‐induced DNA protecting protein (MSMEG_6467) linked with oxidative stress resistance in bacteria (Gupta et al. [2002](#mbo3288-bib-0016){ref-type="ref"}) showed reduced expression in both growth stages. *M. smegmatis* is a saprophyte and dehydrogenase activity is considered to be a good measure of microbial oxidative activity in saprophytes. Many genes (MSMEG_1794, MSMEG_5400, MSMEG_5402, MSMEG_0684) encoding for dehydrogenages and predicted to perform oxidoreductase activity (SmegmaList) were found to be SigF‐dependent and down‐regulated in both growth stages. These are likely to render susceptibility to the mutant strain toward oxidative stress.

In *M. smegmatis*, GPL biosynthesis gene cluster maps to a single locus of \~65 kb in the genome, containing nearly 30 ORFs that included genes for the synthesis as well as transport of GPLs (Ripoll et al. [2007](#mbo3288-bib-0030){ref-type="ref"}). In the genome‐wide gene expression study (see supplementary Data set S1) no genes from GPL biosynthesis gene cluster showed altered regulation in the Δ*sigF* mutant strain. We also did not find the SigF consensus signature in the upstream regions of genes clustered at this locus. This was in line with our earlier observation wherein we did not notice any difference in GPLs profile of Δ*sigF* mutant. However, a complete analysis of polar and nonpolar lipids from Δ*sigF* mutants showed distinct differences in 2D‐TLC profile of nonpolar lipids in mutant strain. Concomitant with these findings trehalose biosynthesis genes (MSMEG_6514, MSMEG_6515) and mycocerosic acid synthase genes (MSMEG_6765 to MSMEG_6767) were found to be significantly down‐regulated in Δ*sigF* strain (Table [1](#mbo3288-tbl-0001){ref-type="table-wrap"}). MSMEG_6515 encodes for trehalose synthase which enables the conversion of glycogen into trehalose. The SigF promoter consensus was identified in the upstream of these genes, indicating that trehalose and mycocerosic acid synthase (MAS) genes are directly regulated by SigF and affect the cell wall architecture by inhibiting lipid biosynthesis pathway in *sigF* mutant.

Post‐translational regulation of SigF in *Mycobacterium smegmatis*: overexpression of *rsbW* mimics the *M. smegmatis* Δ*sigF* mutant phenotype {#mbo3288-sec-0009}
-----------------------------------------------------------------------------------------------------------------------------------------------

Sigma factors activity is post‐translationaly regulated by their cognate anti‐sigma factors, which sequester them and make them unavailable for RNAP. In *M. tuberculosis*, SigF is post‐translationally regulated by its cognate anti‐sigma factor RsbW, which is, in turn, regulated by two anti‐anti‐sigma factors, RsfA and RsfB (Beaucher et al. [2002](#mbo3288-bib-0001){ref-type="ref"}). Both are able to disrupt the RsbW‐SigF complex, releasing SigF to allow its association with RNA polymerase. In *M. smegmatis rsbW* (MSMEG_1803) is colocalized (Fig. S1) and cotranscribed with *sigF* (MSMEG_1804) (Gebhard et al. [2008](#mbo3288-bib-0011){ref-type="ref"}). But, barring the sequence similarity with *M. tuberculosis* RsbW (Rv3287c), there has been no experimental evidence till date which demonstrates that MSRsbW binds to SigF and regulates it negatively. We argued that if MSMEG_1803 is indeed the anti‐*SigF*, RsbW, negatively regulating the SigF in *M. smegmatis*, overexpression of MSMEG_1803 in *M. smegmatis* wild type cells should sequester the prevailing pool of SigF and thereby making them unavailable for binding to RNA polymerase. This will impede the expression of SigF regulon and the MSMEG_1803 overexpressing *M. smegmatis* cells will produce a phenotype akin to *M. smegmatis* Δ*sigF* mutant. As shown in Fig. [5](#mbo3288-fig-0005){ref-type="fig"}(A) and (B), we observed loss of pigmentation and increased susceptibility to oxidative stress in strain MS:MS*rsbW* nearly similar to SFKO1, the Δ*sigF* mutant strain. This proved that MSMEG_1803 indeed encodes for the cognate anti‐SigF protein which binds to SigF in *M. smegmatis* and regulates it negatively. Similar observations were made with *M. smegmatis* wild type cells overexpressing *M. tuberculosis rsbW* (MS:Mtb*rsbW*) (Fig. [5](#mbo3288-fig-0005){ref-type="fig"}A and B), which further established that MSMEG_1803 is true ortholog of Mtb*rsbW*, as both strains produced similar phenotypes akin to SFKO1. To establish that the observed phenotypes of MS:MS*rsbW* and MS:Mtb*rsbW* strains are indeed due to overexpression of *rsbW* and sequestering of SigF proteins we performed real time semiquantitative RT‐PCR of these genes in *M. smegmatis* wild type, SFKO1 and overexpressing recombinant strains. We also examined the expression levels of two putative anti‐anti‐*sigF* proteins RsfA (MSMEG_1786) and RsfB (MSMEG_6127) from *M. smegmatis*, which were identified based on their homology to *M. tuberculosis* RsfA and RsfB. As observed in Fig. [5](#mbo3288-fig-0005){ref-type="fig"}(C) the expression levels of *rsbW*,*rsfA,* and *rsfB* were found to be similar to wild type, while the *sigF* was nearly absent, owing to its deletion, in SFKO1 strain. However, the expressions of these genes were found to be similar in MS:MS*rsbW* and MS:Mtb*rsbW* strains, suggesting that MS*rsbW* (MSMEG_1803) is indeed similar to Mtb*rsbW*. A negligible expression of *sigF* gene was noticed in both strains, which implies that enhanced cellular level of RsbW protein, owing to its overexpression (Fig. [5](#mbo3288-fig-0005){ref-type="fig"}C), completely sequestered the SigF protein, and, in turn shut down the expression of *sigF* gene, which is transcriptionally autoregulated. Since the *sigF* is cotranscribed with *rsbW* the increased *rsbW* level in MS:MS*rsbW* and MS:Mtb*rsbW* strains amounts to the ectopically expressed *rsbW* under the control of *hsp60* ~pr~ in these strains. Interestingly, the expressions of *rsfA* and *rsfB* were also found to be induced, similar to *rsbW*, in both recombinant strains. RsfA and RsfB are known to antagonize RsbW, therefore, it is possible that some feedback machinery in the bacterial cell would have sensed the increased cellular level of RsbW and invoked an ensuing response by transcriptionally upregulating the expression of both anti‐*sigF* antagonists. It may be noted that the expression levels of RsfA (MSMEG_1786) and RsfB (MSMEG_6127) were not significantly altered in Δ*sigF* mutant strain in genome wide gene expression analysis performed in this study and by Hümpel et al. [2010](#mbo3288-bib-0021){ref-type="ref"}. Also both these genes lacked SigF footprints in their upstream regulatory regions.

![Increased susceptibility to oxidative stress (A) and loss of pigmentation (B) in *Mycobacterium smegmatis rsbW* overexpressing strain MS:MS *rsbW* and *M*. *tuberculosis rsbW* overexpressing strain MS:Mtb*rsbW*, nearly similar to Δ*sigF* mutant strain (SFKO1). (C) Relative expressions of *sigF*,*rsbW*,*rsfA,* and *rsfB* in SFKO1, MS:MS *rsbW* and MS:Mtb*rsbW* strains were determined from the RNA samples isolated from log phase cultures. The mRNA levels of *rsbW*,*rsfA,* and *rsfB* appear to be similar to wild type in SFKO1, while the *sigF* mRNA level is several‐fold reduced in SFKO1, MS:MS *rsbW* and MS:Mtb*rsbW* strains. The increased *rsbW* level in MS:MS *rsbW* and MS:Mtb*rsbW* strains amounts to the ectopically expressed *rsbW* under the *hsp60* ~pr~ in these strains. *rsfA* and *rsfB* mRNA levels are also induced in both recombinant strains with respect to the wild type. Expression of genes was normalized with the *sigA* transcript level. The mean value and standard deviations were calculated from two different experiments.](MBO3-4-0896-g005){#mbo3288-fig-0005}

Furthermore, using bacterial two‐hybrid experiment we analyzed the interactions of *M. smegmatis* anti‐SigF RsbW with SigF and its two antagonists RsfA and RsfB. *M. smegmatis* RsbW showed very strong interactions with SigF and RsfA while a comparatively weak interaction was noticed with RsfB (Table [2](#mbo3288-tbl-0002){ref-type="table-wrap"}). Similar results were obtained when we allowed *M. tuberculosis* RsbW to interact with *M. smegmatis* SigF, RsfA, and RsfB (Table [2](#mbo3288-tbl-0002){ref-type="table-wrap"}). On the other hand, we did not notice any interaction when *M. smegmatis* RsbW was allowed to interact with *M. smegmatis* SigA, which confirmed the specificity of MSRsbW to its cognate sigma factor SigF. To further confirm these interactions we performed GST pull down assay. *M. smegmatis* RsbW was overexpressed as GST tagged protein (GST‐MSRsbW) using pET41a+ vector in *Escherichia coli*, purified and immobilized on GST beads. A column was prepared with GST‐MsRsbW immobilized beads and whole cell lysates of recombinant *E. coli* strains overexpressing *M. smegmatis* SigF, RsfA, and RsfB proteins were applied and allowed to bind to GST‐MsRsbW. Subsequently, interacting proteins were eluted using reduced glutathione and electrophoresed on SDS‐PAGE (Sodiumdodecyl sulfate polyacrylamide gel electrophoresis) (Fig. [6](#mbo3288-fig-0006){ref-type="fig"}). Individual bands were excised and sequenced using MALDI/MS (data not shown). We noticed similar level of interactions between RsbW, SigF, RsfA, and RsfB proteins as it was observed in bacterial two‐hybrid assay. Thus, combined together, bacterial two‐hybrid and GST pull down results clearly established that MSMEG_1803 encodes for anti‐SigF RsbW protein in *M*. *smegmatis* which specifically and strongly interacts with its cognate sigma factor SigF and its antagonists RsfA and RsfB. The fact that these proteins showed similar level of interactions with *M. tuberculosis* RsbW suggests that most likely, similar to *M. tuberculosis*, in *M. smegmatis* SigF is post‐translationally regulated by its anti‐sigma factor RsbW, which is in turn regulated by its antagonists RsfA and RsfB. However, further experiments are required to elucidate the regulation of these interactions with respect to different physiological states of mycobacterial cells. It would be of interest to examine whether some more SigF antagonists are present in *M. smegmatis* genome as predicted by Hümpel et al. ([2010](#mbo3288-bib-0021){ref-type="ref"}) in their studies.

###### 

Interactions of anti‐SigF (RsbW) with its antagonists (RsfA and RsfB) and SigF

  Interacting proteins               
  ---------------------------------- -------
  pBT‐LGF2 + pTRG‐GAL11^P^           +++
  pBT + pTRG‐MS*rsbW* (MSMEG_1803)   −
  pBT‐MS*sigA* + pTRG‐MS*rsbW*       −
  pBT‐MS*sigF* + pTRG‐MS*rsbW*       ++++
  pBT‐MS*rsfA* + pTRG‐MS*rsbW*       ++++
  pBT‐MS*rsfB* + pTRG‐MS*rsbW*       ++
  pBT + pTRG‐Mtb*rsbW* (Rv3287c)     −
  pBT‐MS*sigF* + pTRG‐Mtb*rsbW*      ++++
  pBT‐MS*rsfA* + pTRG‐Mtb*rsbW*      +++++
  pBT‐MS*rsfB* + pTRG‐Mtb*rsbW*      ++

Different levels of interactions are denoted as: \<10% (−), 10--20% (+), 20--40% (++), 40--60% (+++), 60--80% (++++), \>80% (+++++). Control vectors carrying bait protein pBT‐LGF2 and target protein pTRG‐GAL11P showed strong (+++) interaction and considered as reference.
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![(A) *Mycobacterium smegmatis* SigF interaction with its anti‐sigma factor MSRsbW using pull‐down assay. Lanes: 1‐ purified GST, 2‐ purified GST‐MSRsbW, 3‐ overexpressed MSSigF, 4‐ GST protein with MSSigF (Eluted with 5 mmol L^−1^ RG), 5‐ GST protein with MSSigF (Eluted with 10 mmol L^−1^ RG), 6‐ GST‐MSRsbW with MSSigF (Eluted with 5 mmol L^−1^ RG), 7‐ GST‐MSRsbW (oval) with MSSigF (rectangle) (Eluted with 10 mmol L^−1^ RG), 8‐ Prestained protein marker. (B) *M. smegmatis* anti‐sigma factor antagonists, RsfA and RsfB, interactions with its anti‐sigma factor MSRsbW using pull‐down assay. Lanes: 1‐ GST‐MSRsbW (oval) with MSRsfA (rectangle) (Eluted with 10 mmol L^−1^ RG), 2‐ GST protein with MSRsfA (Eluted with 10 mmol L^−1^ RG), 3‐ GST‐MSRsbW (oval) with MSRsfB (rectangle) (Eluted with 10 mmol L^−1^ RG), 4‐ GST protein with MSRsfB (Eluted with 10 mmol L^−1^ RG), 5‐ prestained protein marker.](MBO3-4-0896-g006){#mbo3288-fig-0006}

Conclusions {#mbo3288-sec-0010}
===========

In this study, we report that in *M. smegmatis* the SigF is not essential for growth of bacterium. Deletion of *sigF* results in loss of carotenoid pigmentation which rendered increased susceptibility to H~2~O~2~ induced oxidative stress as complementation of Δ*sigF* mutant with carotenoid genes largely restores the phenotype. In *M. smegmatis*,*sigF* deletion altered the outer most layer of the cell envelope and the cell wall lipid composition by modulating the lipid biosynthesis pathway. *M. smegmatis* SigF regulon included variety of genes expressed during exponential and stationary phases of growth and those responsible for oxidative stress, lipid biosynthesis, energy, and central intermediary metabolism. We report the identification of a SigF antagonist, an anti‐sigma factor (RsbW), which upon overexpression in *M. smegmatis* wild type cell produced a phenotype similar to *M. smegmatis* Δ*sigF* mutant. Two anti‐sigma factor antagonists, RsfA and RsfB are also identified and their interactions with anti‐sigma factor were confirmed using bacterial two‐hybrid and GST pull down.

Experimental Procedures {#mbo3288-sec-0011}
=======================

Bacterial strains and culture conditions {#mbo3288-sec-0012}
----------------------------------------

Bacterial strains and plasmids used in this study are described in Table [3](#mbo3288-tbl-0003){ref-type="table-wrap"}. *M. smegmatis* mc^2^155 wild type and derivative strains were grown at 37°C in Middlebrook 7H9 (Difco) liquid culture medium supplemented with 10% albumin‐dextrose‐catalase (ADC), 0.5% glycerol, and 0.05% Tween‐80 or on Middlebrook 7H10 (Difco) solid culture medium supplemented with 10% oleic acid‐albumin‐dextrose‐catalase (OADC) and 0.5% glycerol. *E. coli* cultures were grown in Luria‐Bertani (LB) broth with the addition of ampicilin (100 *μ*g mL^−1^), kanamycin (50 *μ*g mL^−1^), and hygromycin (100 *μ*g mL^−1^), as required.

###### 

Bacterial strains and key plasmids used in this study

  Strains or plasmids                 Relevant properties                                                    Reference or source
  ----------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------
  *Escherichia coli* strains                                                                                 
  *E. coli* DH5*α*                    F^‐^ *φ*80*lac*ZΔM15 Δ(*lac*ZYA‐*arg*F)U169 *rec*A1 *end*A1            Invitrogen
  XL1‐Blue MRF′                       *rec*A1 *gyr*A96 *rel*A1 *lac* \[F′*pro*AB *lac*Iq*Z*Δ*M*15 Kan^r^\]   Agilent Technologies
  XL1‐Blue                            *rec*A1 *gyr*A96 *rel*A1 *lac* \[F*′ lac*Iq *HIS*3 *aadA* (Kan^r^)\]   Agilent Technologies
  pLYSY^+^                            *lac*Iq(Cam^r^)*/fhu*A2 *lacZ*::T7* gene*1 *end*A1                     New England Biolabs
  *E. coli* C41                       Expression vector                                                      Novagen
  Mycobacterial strains                                                                                      
  *Mycobacterium smegmatis* ATCC607   *M. smegmatis* parent strain of mc^2^155                               Late Jean‐Mark Reyrat, University of Paris
  *M. smegmatis* ATCC607 Δ*sigF*      *sigF* deleted ATCC607 strain, Str^r^                                  
  *M. smegmatis* mc^2^155             High transforming *M. smegmatis* strain                                Departmental Stock
  SFKO1                               *sigF* deleted mc^2^155 strain, Hyg^r^                                 This study
  SFKO1/*sigF*                        mc^2^155 Δ*sigF* mutant complemented with *sigF*                       This study
  SFKO1/*crt*                         mc^2^155 Δ*sigF* mutant complemented with *crt*                        This study
  MS:MS*rsb*W                         mc^2^155:*hsp60*pr‐MS*rs*W, Km^r^                                      This study
  MS:Mtb*rsb*W                        mc^2^155:*hsp60*pr‐Mtb*rs*W, Km^r^                                     This study
  *M. tuberculosis* H37Rv             Laboratory strain of tubercle bacilli                                  Departmental Stock
  Plasmids                                                                                                   
  pDrive                              PCR cloning vector, Amp^r^, Km^r^                                      Qiagen, India
  pTZ57R/T                            PCR cloning vector, Amp^r^,                                            Fermentas, India
  pMV261                              *E. coli*‐mycobacterial shuttle vector, Km^r^                          Stover et al. ([1991](#mbo3288-bib-0038){ref-type="ref"});
  pMV306                              Mycobacterial integrative vector, Km^r^                                Stover et al. ([1991](#mbo3288-bib-0038){ref-type="ref"})
  pET28a, 41a(+)                      Expression vectors, Km^r^                                              Novagen
  pTZ*sigF*1                          pTZ carrying MS *sigF* ORF at NcoI‐HindIII                             This study
  pTZ*sigF*2                          pTZ carrying MS *sigF* flanked by XbaI‐BamHI                           This study
  pET*sigF*                           pET28a carrying MS *sigF* at NcoI‐HindIII                              This study
  pDΔ*sigF*                           pDrive carrying *sigF* allelic exchange cassette, hyg^r^               This study
  pMV306*sigF*                        pMV306 containing *hsp60pr‐sigF* at NotI‐HindIII                       This study
  pMV306*crt*                         pMV306 carrying *crt* locus at XbaI‐HindIII                            This study
  pTRG‐MS *rsbW*                      pTRG vector carrying MS *rsbW* ORF at EcoRI‐XhoI, Tet^r^               This study
  pTRG‐Mtb *rsbW*                     pTRG vector carrying Mtb *rsbW* ORF at EcoRI‐XhoI, Tet^r^              This study
  pBT‐MS *sigF*                       pBT vector carrying MS *sigF* ORF at EcoRI‐XhoI, Chl^r^                This study
  pBT‐MS *sigA*                       pBT vector carrying MS *sigA* ORF at EcoRI‐XhoI, Chl^r^                This study
  pBT‐MS *rsfB*                       pBT vector carrying MS *rsfB* ORF at EcoRI‐XhoI, Chl^r^                This study
  pBT‐MS *rsfA*                       pBT vector carrying MS *rsfA* ORF at EcoRI‐XhoI, Chl^r^                This study
  pBT‐LGF2                            Two hybrid interaction control bait plasmid                            Agilent Technologies
  pTRG‐Gal11^P^                       Two hybrid interaction control target plasmid                          Agilent Technologies
  pET41a‐MS *rsbW*                    Expression vector carrying MS *rsbW* ORF at speI‐XhoI, Km^r^           This study
  pET28a‐MS *rsfA*                    Expression vector carrying MS *rsfA* ORF at NdeI‐XhoI, Km^r^           This study
  pET28a‐MS *rsfB*                    Expression vector carrying MS *rsfB* ORF at NdeI‐XhoI, Km^r^           This study
  pMV261‐MS *rsbW*                    pMV261 vector carrying MS *rsbW,* Km^r^                                This study
  pMV261‐Mtb *rsbW*                   pMV261vector carrying Mtb *rsbW,* Km^r^                                This study

Amp^r^, ampicillin resistant; Km^r^, kanamycin resistant; hyg^r^, hygromycin resistant; Tet^r^, tetracycline resistant; Chl^r^, chloramphenicol resistant; Str^r,^ streptomycin resistant.
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DNA manipulation, construction of sigF mutant, and its complementation {#mbo3288-sec-0013}
----------------------------------------------------------------------

Recombinant DNA techniques were performed as per standard procedures (Sambrook et al., [2001](#mbo3288-bib-0101){ref-type="ref"}) using *E. coli* DH5*α* as the initial host. Restriction and DNA modifying enzymes were obtained from Fermentas. Primers used in this study are described in Table [4](#mbo3288-tbl-0004){ref-type="table-wrap"}. Preparation of electrocompetent cells and electroporation were done as previously described (Singh and Singh [2008](#mbo3288-bib-0034){ref-type="ref"}). *M. smegmatis* mutant lacking *sigF* was constructed using allelic exchange method. For this, a hygromycin resistance cassette flanked by nearly 1 kb flanking regions of each side of the *sigF* gene was cloned into pDrive plasmid vector generating pDΔ*sigF*. The final allele exchange cassette contained 5′flank/Hyg^r^/3′flank in pDΔ*sigF*. 5′ and 3′ flanking regions contained a few nucleotide sequences of *sigF* gene which was later used for PCR amplification of *sigF* ORF from wild type and Δ*sigF* mutant. pDrive contains only *E. coli* origin of replication and, therefore, fails to multiply in mycobacteria and serves as suicide vector in mycobacteria. pDΔ*sigF* was electroporated into *M. smegmatis* mc^2^155 and transformants were selected on hygromycin (50 *μ*g mL^−1^) plates. The expected double cross‐over event would exchange *sigF* gene with hygromycin resistance marker in mutant strain. Selected colonies were first screened by PCR using MSSF1 and MSSF2 primers followed by sequencing and finally validated using Southern blotting. Southern blot was carried out using SmaI digested genomic DNA of *M. smegmatis* wild type and putative *sigF* deletion mutants using two probes, one specific for *sigF*‐*rsbW* (Probe 1) and another for *hyg* (Probe 2) (Fig. S1). The probe was labeled using Dig High Prime DNA labeling Kit (Roche) as per manufacturer\'s instructions. Firstly, probe‐1 corresponding to *sigF*‐*rsbW* was hybridized, signals were developed and then after deprobing the blot was rehybridized with probe‐2 corresponding to hygromycin. Blots were developed using chemiluminescence based detection kit (Roche) according to the manufacturer\'s instructions. The confirmed Δ*sigF* mutant strain is designated as SFKO1. For complementation of the Δ*sigF* mutant, *M. smegmatis sigF* ORF was PCR amplified and cloned into the NotI‐HindIII sites of the PMV306 (Stover et al. [1991](#mbo3288-bib-0038){ref-type="ref"}), an integrative *E. coli*/mycobacterial shuttle vector, downstream to *hsp60* promoter to create pMV306*sigF*. Transformation of SFKO1 strain with pMV306*sigF* resulted in strain SFKO1/*sigF*. Similarly, *crt* locus genes were PCR amplified and cloned into the XbaI‐HindIII sites of the PMV306 at the downstream of *hsp60* promoter to create pMV306*crt* and SFKO1was transformed with pMV306*crt* to generate strain SFKO1/*crt*.

###### 

Primers used in this study

  Primers       Sequence (5′ to 3′)
  ------------- ------------------------------------------
  MSSF1         [TCTAGA]{.ul}GTGACGTCGGAATACGCAG
  MSSF2         [AAGCTT]{.ul}CTACTGCAGCTGGTCGCGCA
  pETSF1        A[CCATGG]{.ul}GCCATCATCACCACCAT
  pETSF2        CACCACCATCATATGACGTCGGAA
  SFAE1         [AAGCTT]{.ul}ATGCGGCGCATGG
  SFRT3         AGGCACCGCTCGACGATCTTC
  MSF3′F        [TCTAGA]{.ul}GCGCACCGTGCTGGTGCTGC
  MSF3′R        GATCCTGTCGTGGGATCGTGCGAGAG
  PhytoFR1F     ACTAG[TCTAGA]{.ul}ATGAGCCGCGCGATCCCGCGAC
  PhytoFR2R     ACTAG[AAGCTT]{.ul}CGCCGCCACCGGCGGTGTGGTG
  Real time     
  MysART4       CATCTCGCTGGACCAGAC
  MysART6       TGCAGCAGCGTGAACGACAC
  SFRT1         GTGACGTCGGAATACGCAGACG
  SFRT2         TCCGAGCCGCAAGTGGAGTTCC
  MS 1802F      GGTCGGCAGAGGGAGTCGAC
  MS 1802R      TTCTCGATAGCGGTCACCAG
  MS 0670F      CCTACTCCACTTTCACATTC
  MS 0670R      TACTGCATACCGGTGGCGAG
  MS 1782F      TGGACTCCTTCGAATCCGAC
  MS 1782R      GGTTTGTCGGCCATGTCCTC
  MS 2594F      GCCATGGCAGAGACGATGTC
  MS 2594R      CCGCTTCGGTCAGATCAATG
  MS 6727F      TCATCCTCGGCGACGTGCTC
  MS 6727F      GTGAGCAGGGCCAACATCAG
  MS 1769F      TGACGAACCTGTCGATCATG
  MS 1769R      ACCAGGCTGCTCACGAACAC
  MS 6232F      ACCGTGACGTGCTGACCGAC
  MS 6232R      TCTTCTCCAGGAAGTGGTAG
  MS 2837F      CGCAACGTGTCGATCGATAC
  MS 2837F      ACGATGCGTCCGTCCTTGAC
  MS 2347F      GGCGGTTACCGGATCGACAC
  MS 2347R      GGGAGCAACTGCAGGCGGTC
  1803RTF       GAAACACCCGCTCGGGGCGA
  1803RTR       CGTCGAAGTCGAGGTCCTCGA
  Ms*rsfA*RTF   CAGCGTTGCCAAGAGGAGTA
  MS*rsfA*RTR   TGGAGGCATCCAGGTCGCCG
  MS*rsfB*RTF   CGAGCCAGGACCCGGCGAA
  MS*rsfB*RTR   GGAACCGATCGCGTCTTCGA
  Two Hybrid    
  MS *sigA*1    AC[GAATTC]{.ul}GTGGCAGCGACAAAGGCA
  MS *sigA*2    GCA[CTCGAG]{.ul}CTAGTCCAGGTAGT
  MS *rsbW*1    CTG[GAATTC]{.ul}AGATGGCGGAAACACC
  MS *rsbW*2    CTG[CTCGAG]{.ul}TCACCGCAGCAGGC
  Mtb *rsbW*1   CTG[GAATTC]{.ul}AGATGGCCGACTCGG
  Mtb *rsbW*2   GCA[CTCGAG]{.ul}TCACCTGCTGGATG
  MS *sigF*1    AGT[GAATTC]{.ul}CATGACGTCGGAATAC
  MS *sigF*2    GCA[CTGGAG]{.ul}CTACTGCAGCTGGTC
  MS *rsfB*1    TGA[GAATTC]{.ul}CATGACGAGCCAGGAC
  MS *rsfB*2    AGT[CTCGAG]{.ul}TTATGTCTTCAACGACG
  MS *rsfA*1    G[GAATTC]{.ul}ATGCCCACAATCAGCG
  MS *rsfA*2    AGT[CTCGAG]{.ul}CTAGGTGTTCTCCACC
  Pull down     
  MS *rsbW*3    CA[ACTAGT]{.ul}ATGGCGGAAACACCCG
  MS *rsbW*2    CTG[CTCGAG]{.ul}TCACCGCAGCAGGC
  Mtb *rsbW*3   CA[ACTAGT]{.ul}ATG GCCGACTCGGATT
  Mtb *rsbW*2   GCA[CTCGAG]{.ul}TCACCTGCTGGATG
  MS *rsfA*HF   AGC[CATATG]{.ul}CCCACAATCAGCGTTGC
  MS *rsfA*HR   TCA[CTCGAG]{.ul}CTAGGTGTTCTCCACCAG
  MS *rsfB*HF   AGC[CATATG]{.ul}ACGAGACCAGGACCCGGCGA
  MS *rsfB*HR   TCA[CTCGAG]{.ul}TTATGTCTTCAACGA
  pETSF1        A[CCATGG]{.ul}GCCATCATCACCACCAT
  pETSF2        CACCACCATCATATGACGTCGGAA

Restriction sites relevant to procedures used in this work are underlined.

John Wiley & Sons, Ltd

Susceptibility of *Mycobacterium smegmatis* strains to oxidative stress {#mbo3288-sec-0014}
-----------------------------------------------------------------------

For stress experiments, different *M. smegmatis* strains were grown to 0.6--0.8 OD~600~ (exponential phase) and 2.6--2.8 OD~600~ (stationary phase) and then cultures were split into aliquots. For oxidative stress, cultures were treated with H~2~O~2~ (10 mmol L^−1^), allowed to grow for 4 h at 37°C and plated thereafter in duplicates following 10‐fold serial dilution for CFU analysis. Untreated cultures were taken as control for stress experiments. The total number of colonies that appeared in the untreated control was considered 100%. Data were collected from three different experiments. The mean values and standard deviations were plotted for each set of data.

For inhibition of carotenoid biosynthesis, initially the dose of diphenylamine (DPA) was set so that ≥ 80% of *M. smegmatis* mc^2^155 wild type cells survive after DPA treatment. 0.1 mmol L^−1^ DPA treatment for 4--6 h ensured the survival of 80% wild type cells. Further experiments with different *M. smegmatis* strains (Fig. [2](#mbo3288-fig-0002){ref-type="fig"}) were performed with exponentially grown culture at similar OD values (0.6--0.8). Cultures were incubated with 0.1 mmol L^−1^ DPA for 2 h before H~2~O~2~ treatment and stress susceptibility was analysed as described above.

Generation of anti‐SigF antibody and immunodetection of SigF {#mbo3288-sec-0015}
------------------------------------------------------------

The *M. smegmatis sigF* ORF was amplified using gene‐specific primers and cloned into PCR cloning vector pTZ57R/T. The clone was verified by DNA sequencing following which the ORF was relocated to the pET28a+ expression vector generating pETSigF. SigF was overexpressed as N‐terminal His~6~‐tagged recombinant in *E. coli* C41 cells, purified using Ni--NTA affinity chromatography and the purified His~6~‐SigF was used to raise anti‐SigF antibody in female New Zealand white rabbit, as described previously (Biswas et al. [2013](#mbo3288-bib-0003){ref-type="ref"}). Immunodetection was performed with the primary antibody (polyclonal sera at 1:2000), followed by washing and incubation with the secondary antibody (anti‐rabbit IgG horseradish peroxidase conjugate at 1:40,000). The blots were developed using the chemiluminescent substrate (Pierce) and the signals were captured on the Bio‐Rad Chemidoc system.

Transmission electron microscopy {#mbo3288-sec-0016}
--------------------------------

Electron microscopy samples were prepared as described previously (Paul and Beveridge [1992](#mbo3288-bib-0028){ref-type="ref"}). Briefly, fully grown cultures of *M. smegmatis* strains were diluted (1:100) in fresh LBGT broth and allowed to grow till 0.5 OD~600~. Cultures were centrifuged at 400 × g for 2 min to separate homogenous cell suspension from cell aggregates. Homogenous suspensions were transferred to new tubes and cells were harvested by centrifugation at 2600 × g for 5 min. Cells were washed five times with 0.1 mol L^−1^ cacodylate buffer (pH 6.8) and pellets (\~50 mg wet weight) were fixed in 2.5% (w/v) glutaraldehyde, 0.05% ruthenium red in 0.1 mmol L^−1^ cacodylate buffer in dark at 4°C overnight. Cells were collected by centrifugation, washed thrice in 0.1 mol L^−1^ cacodylate buffer before fixing for 2 h in dark in 1% (w/v) osmium tetroxide, 0.05% ruthenium red in 0.1 mol L^−1^ cacodylate buffer. After this cells were washed thrice in 0.1 mol L^−1^ cacodylate buffer for 5 min each and embedded in 2% agarose gel. Blocks were dehydrated through a graded ethanol series of 20, 40, 60, 80, and 95% for 5 min each followed by two 10 min washes in absolute ethanol. Samples were embedded in EPON 812 resin at 60°C for 48 h. Ultra thin sections (50--70 nm) were obtained using Ultracut Ultra Microtome (Leica) and picked upon 200 mesh copper grids. Sections were poststained with uranyl acetate and Reynold\'s lead citrate. Microscopy was performed on a Philips FEI Technai‐12 Twin Transmission Electron Microscope and images were recorded using a SIS mega View II CCD camera attached with the microscope.

Extraction and analysis of GPLs and total lipids from *Mycobacterium smegmatis* {#mbo3288-sec-0017}
-------------------------------------------------------------------------------

GPLs extraction and analysis were performed as described earlier (Vats et al. [2012](#mbo3288-bib-0040){ref-type="ref"}). The *M. smegmatis* wild type and mutant strains were grown in Middlebrook 7H9 medium supplemented with 10% ADC till late stationary phase (2.8--3.0 OD~600~). GPLs were extracted with CHCl~3~/CH~3~OH (2:1) at room temperature for 24 h. The supernatant was dried using rotatory evaporator till dryness. The lipid extract was deacetylated by 0.2 mmol L^−1^ NaOH in methanol at 37°C for 1 h followed by neutralization with glacial acetic acid. After drying, lipids were dissolved in CHCl~3~/CH~3~OH (2:1), spotted onto the TLC plate (Aluminium baked silica gel 60 F254) (Merck) and developed in CHCl~3~/CH~3~OH/H~2~O (90:10:1) solvent. GPLs were visualized by spraying with 5% *α*‐naphthol/sulfuric acid in ethanol followed by charring at 120°C for 10 min. The four de‐*O*‐acetylated GPLs (dGPLs) were named dGPL I, II, III, and IV, starting from the solvent front. For mass analysis GPLs were analysed and identified by ESI‐Q‐TOF‐MS (Absciex). \[M+Na\]^+^ ions of deacetylated GPLI, GPLII, GPLIII, and GPLIV were observed at *m/z* 1187, 1173, 1173, and 1159 respectively (Khoo et al. [1995](#mbo3288-bib-0023){ref-type="ref"}; Vats et al. [2012](#mbo3288-bib-0040){ref-type="ref"}).

Extractions and analysis of lipids were performed as described earlier (Slayden and Barry [2001](#mbo3288-bib-0036){ref-type="ref"}). Lipids were extracted from freeze dried stationary phase grown *M. smegmatis* cells. Bacterial cells were resuspended in equal volume of methanolic saline and petroleum ether, mixture was stirred for 12--16 h and then allowed to separate following which nonaqueous phase containing the nonpolar lipids were removed and stored. An equal volume of petroleum ether was added to lower aqueous phase, mixture was stirred for 2 to 4 h, nonaqueous layer was removed and pooled with the first one. Nonpolar lipids were dried using a rotatory evaporator and resuspended in dichloromethane. Extraction of polar lipids was performed by adding chloroform (CHCl~3~), CH~3~OH, and 0.3% aqueous NaCl (9:10:3) to the extract. The entire mixture was stirred for 4 h and the solvent extract was separated from the biomass. Furthermore, the residues were extracted with CHCl~3~, CH~3~OH, and 0.3% aqueous NaCl (3:10:4) for 4 h. The polar lipid extracts were mixed with CHCl~3~ and 0.3% aqueous NaCl in equal ratio and the lower organic layer was separated discarding the upper aqueous layer. Polar lipids were dried using rotatory evaporator and resuspended in CHCl~3~ and CH~3~OH (2:1). 100 *μ*g of lipid extracts were spotted onto the TLC plate (aluminium baked silica gel 60 F254) (Merck) and developed using solvent systems described below. Lipids were detected by charring with 5% phosphomolybdic acid (MPA, Sigma‐Aldrich) in ethanol.

The solvent systems for 2D‐TLC: **System A:** (1) petroleum ether/ethyl acetate (98:2, three times) (2) petroleum ether/acetone (98:2). **System B:** (1) petroleum ether/acetone (92:8, three times) (2) toluene/acetone (95:5). **System C:** (1) chloroform/methanol (96:4) (2) toluene/acetone (80:20). **System D:** (1) chloroform/methanol/water (100:14:0.8) (2) chloroform/acetone/methanol/water (50:60:2.5:3). **System E:** (1) chloroform/methanol/water (60:30:6) (2) chloroform/acetic acid/methanol/water (40:25:3:6).

Protein‐protein interaction analyses using bacterial two‐hybrid {#mbo3288-sec-0018}
---------------------------------------------------------------

BacterioMatch II two‐hybrid system (Agilent Technologies) was used for analyses of protein‐protein interactions. The system utilizes a double *HIS*3‐*aadA* reporter cassette which identifies interacting partners with plausibly reduced background. Detection of protein‐protein interactions is based on transcriptional activation of the *HIS3* reporter gene, which allows growth in the presence of 3‐amino‐1, 2, 4‐triazole (3‐AT), a competitive inhibitor of His3 enzyme. Positives are reconfirmed by using the *aadA* gene, which confers streptomycin resistance, as a secondary reporter.

*Mycobacterium smegmatis sigF*,*sigA*, anti‐*sigF rsbW* (MSMEG_1803), and anti‐*sigF* antagonists, *rsfA* (MSMEG_1786) and *rsfB* (MSMEG_6127) were amplified using gene specific primers (Table [4](#mbo3288-tbl-0004){ref-type="table-wrap"}) and cloned into bait vector pBT at given enzyme sites (Table [3](#mbo3288-tbl-0003){ref-type="table-wrap"}). Similarly, anti‐sigma factors from *M. smegmatis* (MS*rsbW*) and *M. tuberculosis* (Mtb*rsbW*) were amplified using gene specific primers (Table [4](#mbo3288-tbl-0004){ref-type="table-wrap"}) and cloned into target vector pTRG at given enzyme sites (Table [3](#mbo3288-tbl-0003){ref-type="table-wrap"}). All cloning steps were performed in *E. coli* XL1Blue strain, and the clones were verified by restriction digestion and DNA sequencing. To analyze interactions between two proteins, plasmid pairs carrying ORFs in pBT and pTRG vectors were cotransformed in XL1Blue derived reporter strain, provided with two‐hybrid system. Cotransformants were selected on M9 and M9‐3AT plates. The cotransformant containing pBT‐LGF2 and pTRG‐GaL11^P^ (Agilent) was used as a positive control for expected growth on the selective screening medium (M9 with 5 mmol L^−1^ 3‐AT). A cotransformant containing the empty vectors pBT and pTRG was used as a negative control. Further positives were verified using second reporter gene (*aadA)*, conferring streptomycin resistance. The interaction between the bait and target proteins was revalidated by patching cells from a putative positive colony from a selective screening medium (M9‐3AT) plate onto a dual selective screening medium (M9‐3AT + streptomycin 15 *μ*g mL^−1^) plate. CFU obtained on the nonselective screening medium (M9 without 3AT) and selective medium (M9‐3AT) plates were counted, and values were used to determine the percent interaction. The average and standard deviations were determined from data generated from two different experiments.

Cloning, expression, purification of RsbW, SigF, RsfA and RsfB and GST pull down assay {#mbo3288-sec-0019}
--------------------------------------------------------------------------------------

*Mycobacterium smegmatis rsbW* ORF was amplified using gene specific primers and cloned into pET41a+ at SpeI and XhoI sites to generate pET41a‐MS*rsbW*. This allowed MS*rsbW* to be cloned in fusion with GST at its N‐terminal. Positive clones were verified by restriction digestion and DNA sequencing. Recombinant pET41a‐MS*rsbW* and pET41a+ plasmid carrying GST were separately transformed into *E. coli* pLysY^+^ cells and the transformants were selected on kanamycin. Selected colonies were allowed to grow till 0.6 OD~600~ and induced with 1 mmol L^−1^ IPTG at 30°C with continuous shaking for 4 h. Cells were pelleted by brief centrifugation and washed with cold PBS. The pellet was resuspended in buffer (50 mmol L^−1^ Tris pH 7.2, 100 mmol L^−1^ NaCl, 1 mmol L^−1^ DTT and 1% protease inhibitor cocktail), lysed by sonication on ice and then both proteins were purified using glutathione--sepharose resin (Pierce) as per manufacturer\'s instructions. The purified proteins were analyzed by SDS/PAGE.

*Mycobacterium smegmatis sigF*,*rsfA,* and *rsfB* were amplified using gene specific primers and cloned into pET28a at NcoI‐HindIII (*sigF*) and NdeI‐XhoI (*rsfA* and *rsfB*) enzyme sites. The clones were verified by restriction digestion and DNA sequencing. Recombinant pET28a carrying *sigF, rsfA, and rsfB* in fusion with N‐terminal His~6~ tag were transformed into *E. coli* pLysY^+^ cells separately and transformants were appropriately selected. Selected colonies of pET28a‐MS*sigF*, pET28a‐ MS*rsfA,* and pET28a‐MS*rsfB* were grown, proteins were overexpressed and cell lysates were prepared as described above.

Pull down experiments were performed using Pierce GST Protein Interaction Pull‐Down Kit (cat \# PI21516) according to manufacturer\'s instructions. Purified GST‐MS*rsbW* and GST proteins (5 *μ*g each) were allowed to bind 50 *μ*L GST resins at 4°C for 1 h. GST proteins were used as negative control. After several washings (wash buffer 1) columns carrying GST‐MS*rsbW* and GST bound resins were incubated separately with total cell lysates containing overexpressed *M. smegmatis* SigF, RsfA, and RsfB in buffer (TBS: 50 mmol L^−1^ Tris pH 7.4, 100 mmol L^−1^ NaCl) at 4°C for 1 h with constant mixing. After washing five times with 400 *μ*L of wash buffer (wash buffer 1) the bound proteins were eluted in TBS containing 5 and 10 mmol L^−1^ reduced glutathione (RG). Eluted samples were boiled in 1X sample buffer, separated using 15% SDS‐PAGE and visualized by coomassie staining (Fig. [6](#mbo3288-fig-0006){ref-type="fig"}). Individual bands were excised and analysed using MS/MS, which confirmed the identity of eluted proteins.

Overexpression of **rsbW** from *Mycobacterium smegmatis* and *M. tuberculosis* {#mbo3288-sec-0020}
-------------------------------------------------------------------------------

Anti‐sigma factors from *M. smegmatis* and *M. tuberculosis* were subcloned into *E. coli*/mycobacterial plasmid shuttle vector pMV261(Stover et al. [1991](#mbo3288-bib-0038){ref-type="ref"}) to the downstream of *hsp60* promoter. *M. smegmatis* mc^2^155 wild type strain was subsequently transformed with pMV261‐MS*rsbW* and pMV261‐Mtb*rsbW* to generate MS:MS*rsbW* and MS:Mtb*rsbW* recombinant strains respectively. These strains were used for different analysis as described above.

RNA isolation and labeling {#mbo3288-sec-0021}
--------------------------

*Mycobacterium smegmatis* strains were grown in Middlebrook 7H9 broth supplemented with 10% ADC, 0.2% glycerol and 0.05% Tween‐80 at 37°C. Aliquots were removed at exponential (\~0.8 OD~600~) and stationary (\~2.8 OD~600~) phase. Cells were harvested by centrifugation at 2500 × g for 5 min and RNA was extracted using Trizol (Invitrogen, USA), as described earlier (Singh and Singh [2009](#mbo3288-bib-0035){ref-type="ref"}). The RNA was resuspended in 50 *μ*l of RNasefree water. RNA concentration and purity was determined using the NanoDrop^®^ ND‐1000 spectrophotometer (NanoDrop Technologies) and the integrity of total RNA was verified on an Agilent 2100 Bioanalyzer using the RNA 6000 Nano LabChip (Agilent Technologies). RNA was stored at −80°C until use. For labeling, RNA was polyadenylated using Poly (A) polymerase tailing kit (Cat \# PAP5104H, Epicentre Biotechnologies) essentially as per manufacturer\'s instructions. Postpolyadenylation RNA was precipitated with ethanol, washed with 70% ethanol, dried at RT, and dissolved in nuclease free water. RNA concentration was estimated using NanoDrop and kept at −80°C until further use. Quick‐Amp Labeling kit (Agilent technologies) was used for cDNA synthesis and subsequent amplification and labeling by in vitro transcription was done as per one‐color labeling protocol (Agilent, version 5.5). Briefly, 0.5 *μ*g of each of the RNA sample was converted to double stranded cDNA using oligo dT primer with T7 polymerase promoter. RNA samples were mixed with T7 primers and final volume of each reaction was made up to 11.5 *μ*l with nuclease free water. Samples were denatured at 65°C for 10 min and placed on ice for 5 min. cDNA master mix was added to each sample and reactions were kept at 40°C for 2 h followed by incubation at 65°C for 15 min and on ice for 5 min. Then 60 *μ*l of transcription mix was added to each reaction and incubated at 40°C for 2 h. cRNA was generated by in vitro transcription using T7 RNA polymerase and the dye Cy3‐CTP was incorporated during this step. Labeled cRNA was purified using RNeasy Mini kit (Qiagen, India) and their quality was assessed for yields and specific activity using NanoDrop. Specific activity was calculated as picomole of dye/*μ*g of cRNA. Specific activity of ≥ 6.5 was considered optimal and used for hybridization.

Microarray slides, hybridization, and scanning {#mbo3288-sec-0022}
----------------------------------------------

Complete microarray experiment was carried out in technical collaboration with Genotypic Solution, Bangalore, India, official service partner of Agilent Technologies (USA). Array was spotted using 60 mer oligo probes (features) in 8 x15K format (Ref No: AMADID: 016421). Average number of probes per gene in each array is 3. Probes were designed in such a way that multiple probes for a given gene specifically hybridize to different parts of the transcript. Each array carried Agilent proprietary probes for quality control purpose. *M. smegmatis* microarray slides were hybridized with the labeled cRNA. Before hybridization 0.6 *μ*g of each Cy3 labeled cRNAs were fragmented to uniform size of 200 bp to avoid folding up of long transcripts and also remove any steric hindrance which may arise due to secondary structure in long RNA molecules during hybridization. Fragmentation and hybridization were carried out using the Gene Expression Hybridization kit (Part \# 5188--5242, Agilent Technologies). Hybridization was carried out in Agilent\'s Surehyb Chambers at 65°C for 16 h. After hybridization slides were washed using Agilent Gene Expression wash buffers, first at RT and then twice at 37°C. Slides were quickly dried and scanned using the Agilent Microarray Scanner G Model G2565BA at 5 micron resolution. The images were manually verified and found to be devoid of uneven hybridization, streaks, blobs, and other artifacts.

Feature extraction and data analysis {#mbo3288-sec-0023}
------------------------------------

Data extraction from images was done using Feature Extraction software v 10.5.1.1 (Agilent). Feature extracted data were analyzed using GeneSpring GX v 7.3.1 software (Agilent). Normalization of the data was done in GeneSpring GX using the recommended one color Per Chip and Per Gene Data Transformation: Set measurements \<0.01 to 0.01 per Chip: Normalize to 50th percentile per Gene: Normalize to Specific Samples. The gene expression ratio (Δ*sigF*/WT) of ≤ 0.5 or ≥2.0 (*P *≤* *0.05) was considered differentially regulated and filtered from the data. Fold‐chage refers to expression ratio of Δ*sigF* strain to wild‐type and is expressed in log2. Ratios were tested for significance using student *T*‐test from Agilent\'s Gene Spring GX version 7.3 software.

Real‐time reverse transcription‐PCR (RT‐PCR) analyses {#mbo3288-sec-0024}
-----------------------------------------------------

RNA was extracted from exponential and stationary phase cultures of *M. smegmatis* wild type and derivative strains (SFKO1, SFKO1/*sigF*, MS:MS*rsbW* and MS:Mtb*rsbW*) as described earlier (Singh and Singh [2009](#mbo3288-bib-0035){ref-type="ref"}). DNase treatement was carried out to remove any DNA contamination, and post‐treatment RNA was reverse transcribed using random primers and Transcriptor reverse transcriptase (Roche). qRT‐PCR was performed in triplicates using SYBR Green master mix on a Roche 480 LightCycler, as described previously (Singh and Singh [2009](#mbo3288-bib-0035){ref-type="ref"}). Expression of target genes was normalized with the *sigA* transcript level. RNA samples that had not been reverse transcribed were included as controls in all the experiments. The mean relative expression levels and SD were determined from the data generated from two different experiments. Each experiment was set up in triplicates.

Microarray data accession number {#mbo3288-sec-0025}
--------------------------------

All experimental details and data have been deposited at the Gene Expression Omnibus (GEO, NCBI) under accession number GSE19774.

Statistical analysis {#mbo3288-sec-0026}
--------------------

Significant differences between experimental groups were determined using Student\'s *t*‐test (GRAPHPAD PRISM 5, GraphPad Software, Inc., La Jolla, CA). For all analyses, a *P*‐value of \<0.05 was considered statistically significant.
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**Data S1.** Log phase and stationary base.
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**Figure S1.** Schematic of *sigF* locus and construction of *sigF* mutant.
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###### 

**Figure S2.** TLC profile of the de‐*O*‐acetylated GPLs, extracted from the *Mycobacterium smegmatis* WT (MS) and mutant strain (SFKO1), as described in methods. dGPL I, II, III, and IV, starting from the solvent front. Mass spectra profile of GPLs (I, II, III, and IV) extracted from *M. smegmatis* wild type (A) *and* Δ*sigF* mutant (B).
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**Figure S3**. Real time RT‐PCR analysis of select genes from microarray data that were found to be down‐regulated in Δ*sigF* mutant.
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Click here for additional data file.
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